US20130316401A1 - Method for Modifying a Property of a Protein - Google Patents
Method for Modifying a Property of a Protein Download PDFInfo
- Publication number
- US20130316401A1 US20130316401A1 US13/939,291 US201313939291A US2013316401A1 US 20130316401 A1 US20130316401 A1 US 20130316401A1 US 201313939291 A US201313939291 A US 201313939291A US 2013316401 A1 US2013316401 A1 US 2013316401A1
- Authority
- US
- United States
- Prior art keywords
- amino acid
- microorganism
- protein
- substitution
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 180
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 title claims abstract description 43
- 238000006467 substitution reaction Methods 0.000 claims abstract description 143
- 235000001014 amino acid Nutrition 0.000 claims abstract description 101
- 235000018102 proteins Nutrition 0.000 claims abstract description 82
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims abstract description 12
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims abstract description 9
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims abstract description 7
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims abstract description 7
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 6
- 244000005700 microbiome Species 0.000 claims description 125
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 28
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 230000014509 gene expression Effects 0.000 claims description 3
- 239000013611 chromosomal DNA Substances 0.000 claims description 2
- 241000186254 coryneform bacterium Species 0.000 claims 3
- 150000001413 amino acids Chemical group 0.000 description 126
- 102000004190 Enzymes Human genes 0.000 description 58
- 108090000790 Enzymes Proteins 0.000 description 58
- 241001644925 Corynebacterium efficiens Species 0.000 description 49
- 230000012010 growth Effects 0.000 description 37
- 239000000243 solution Substances 0.000 description 34
- 239000011541 reaction mixture Substances 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 28
- 241000894006 Bacteria Species 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 18
- 238000005259 measurement Methods 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 16
- 239000006228 supernatant Substances 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 12
- 239000011159 matrix material Substances 0.000 description 12
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- 235000013922 glutamic acid Nutrition 0.000 description 10
- 239000004220 glutamic acid Substances 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 10
- 239000013587 production medium Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 238000002525 ultrasonication Methods 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 150000007523 nucleic acids Chemical class 0.000 description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 8
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108020003285 Isocitrate lyase Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 5
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 5
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 5
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 5
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 5
- 239000004472 Lysine Substances 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 102000001105 Phosphofructokinases Human genes 0.000 description 5
- 108010069341 Phosphofructokinases Proteins 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 5
- 239000001103 potassium chloride Substances 0.000 description 5
- 235000011164 potassium chloride Nutrition 0.000 description 5
- 241000894007 species Species 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 4
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 4
- 102000009836 Aconitate hydratase Human genes 0.000 description 4
- 108010009924 Aconitate hydratase Proteins 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 108010055400 Aspartate kinase Proteins 0.000 description 4
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 4
- 102000006732 Citrate synthase Human genes 0.000 description 4
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 4
- 239000007836 KH2PO4 Substances 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 108010056578 diaminopimelate dehydrogenase Proteins 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229960000310 isoleucine Drugs 0.000 description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 4
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 4
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- 239000004474 valine Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 3
- 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 3
- 108030003594 Diaminopimelate decarboxylases Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 3
- HOSWPDPVFBCLSY-VKHMYHEASA-N L-aspartic 4-semialdehyde Chemical compound [O-]C(=O)[C@@H]([NH3+])CC=O HOSWPDPVFBCLSY-VKHMYHEASA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 3
- 102000001253 Protein Kinase Human genes 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 229960005261 aspartic acid Drugs 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- 108010023317 1-phosphofructokinase Proteins 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 241000337023 Corynebacterium thermoaminogenes Species 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 108010021466 Mutant Proteins Proteins 0.000 description 2
- 102000008300 Mutant Proteins Human genes 0.000 description 2
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- BIQSIHSUENWJGR-LHWPGRLPSA-L disodium;(2s)-2-aminopentanedioate;hydrate Chemical compound O.[Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O BIQSIHSUENWJGR-LHWPGRLPSA-L 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- ZKLLSNQJRLJIGT-UYFOZJQFSA-N keto-D-fructose 1-phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)COP(O)(O)=O ZKLLSNQJRLJIGT-UYFOZJQFSA-N 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- HNZZAEBYPPNVOF-DHYYHALDSA-N (2s)-2-amino-3-methylbutanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O HNZZAEBYPPNVOF-DHYYHALDSA-N 0.000 description 1
- TYBFYWFTPNZNIS-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)[C@@H](N)CC(O)=O TYBFYWFTPNZNIS-DKWTVANSSA-N 0.000 description 1
- YUXKOWPNKJSTPQ-AXWWPMSFSA-N (2s,3r)-2-amino-3-hydroxybutanoic acid;(2s)-2-amino-3-hydroxypropanoic acid Chemical compound OC[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O YUXKOWPNKJSTPQ-AXWWPMSFSA-N 0.000 description 1
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 1
- UWOCFOFVIBZJGH-UHFFFAOYSA-N 2,3-dihydrodipicolinic acid Chemical compound OC(=O)C1CC=CC(C(O)=O)=N1 UWOCFOFVIBZJGH-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- KPVQNXLUPNWQHM-RBEMOOQDSA-N 3-acetylpyridine adenine dinucleotide Chemical compound CC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 KPVQNXLUPNWQHM-RBEMOOQDSA-N 0.000 description 1
- NLNJLZRQHDZFBV-UHFFFAOYSA-N 3-hydroxy-4-oxo-1h-pyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=CC(O)=C1O NLNJLZRQHDZFBV-UHFFFAOYSA-N 0.000 description 1
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 1
- HZYFHQOWCFUSOV-IMJSIDKUSA-N Asn-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O HZYFHQOWCFUSOV-IMJSIDKUSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- OPINTGHFESTVAX-BQBZGAKWSA-N Gln-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N OPINTGHFESTVAX-BQBZGAKWSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 1
- HWMVXEKEEAIYGB-UHFFFAOYSA-K Isocitric acid, DL- Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O HWMVXEKEEAIYGB-UHFFFAOYSA-K 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 1
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 1
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- CLEJXNXDIYBJSQ-UHFFFAOYSA-L calcium;dichloride;heptahydrate Chemical compound O.O.O.O.O.O.O.[Cl-].[Cl-].[Ca+2] CLEJXNXDIYBJSQ-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- OQRBCLLVAUWAKU-UHFFFAOYSA-L copper;sulfate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O OQRBCLLVAUWAKU-UHFFFAOYSA-L 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- OQTQHQORDRKHFW-UHFFFAOYSA-L manganese(2+);sulfate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O OQTQHQORDRKHFW-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- ZEDAGFBWUVYFQU-UHFFFAOYSA-M sodium;3-morpholin-4-ylpropane-1-sulfonate;hydrate Chemical compound [OH-].[Na+].OS(=O)(=O)CCCN1CCOCC1 ZEDAGFBWUVYFQU-UHFFFAOYSA-M 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
- C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Definitions
- the present invention relates to a method for modifying a property of a protein.
- the present invention also relates to a method for producing a protein which has a modified property, and a method for producing a microorganism which has a modified property.
- the present invention is useful in the field of microbial industrial production and the like.
- Proteins and microorganisms which have an activity in an environment which is different from that in environments preferred by usual microorganisms may have advantages over other proteins and microorganisms.
- proteins which are active at a high temperature in particular, thermostable enzymes, are advantageous over those that are inactivated at high temperatures because they do not need to be cooled to be active.
- thermostable proteins are often produced by bacteria known as thermophilic bacteria, which can grow at a high temperature. Accordingly, when a thermostable protein is designed, amino acid sequences of corresponding proteins within a group of such thermophilic bacteria are analyzed, and commonly observed characteristics in the amino acid sequences are used for reference in many cases.
- thermophilic bacteria techniques for analyzing three-dimensional structures of proteins produced by thermophilic bacteria, estimating a structure which imparts thermostability based on this information, and modifying the structure of a non-thermostable protein so as to have such a structure, and the like, are employed. Furthermore, a method has been proposed in which amino acid sequences of evolutionarily corresponding proteins derived from two or more species in an evolutionary tree are compared, and an amino acid sequence of a proper ancestral protein estimated to be a protein of a hyperthermophilic bacterium is estimated to improve the thermostability.
- Objects of the present invention are to provide a method for modifying a property of a protein, for example, thermostability, a method for producing a protein having said modified property, and a method for producing a microorganism having said modified property.
- thermostability of a protein comprising introducing into said protein two or more amino acid substitutions selected from the group consisting of:
- the inventors of the present invention assiduously studied in order to achieve the above objects. As a result, they found that by using the genome sequences of closely related microorganisms which show a difference in a certain property and comparing the primary structure information of a large number of proteins, amino acid substitutions contributing to the identified property could be determined. Then, they took note of thermostability as a property of a protein. They concluded that amino acid substitutions contributing to thermostabilization could be predicted by comparing moderately thermophilic bacteria growing at about 55 to 74° C. or bacteria which show an even lower optimum growth temperature, but not hyperthermophilic bacteria which grow at about 75° C. or higher, with closely related bacteria with a clearly lower optimum growth temperature.
- amino acid substitutions which might be involved in temperature resistance could be precisely predicted by comparing a large number of amino acid sequences of orthologous genes extracted from the genome sequences of two types of closely related bacteria showing different optimum growth temperatures, that is, bacteria of a thermophilic type and a mesophilic type, and thus accomplished the present invention.
- the method for modifying a property of a protein of the present invention comprises the following steps of:
- the optimum growth condition or optimum conditions for growth means a condition suitable for survival or growth of a microorganism, and examples thereof include optimum growth temperature, optimum growth pH, optimum growth osmotic pressure and so forth. Properties of proteins to be modified by the present invention which correspond to these optimum growth conditions, and examples thereof include thermostability, acid or alkali resistance, halophilism and so forth.
- the degree of difference between the two chosen microorganims in their optimum growth condition is not particularly limited so long as those of the first microorganism and the second microorganism are different. However, for example, when the condition is growth temperature, the optimum growth temperatures are preferably different by 5° C. or more.
- the two types of closely related microorganisms having a difference in at least one their optimum growth conditions are used as information sources of amino acid substitutions that can impart a desired property to a protein.
- the second microorganism closely relating to the first microorganism include microorganisms that have taxonomic properties similar to those of the first microorganism or are at a close evolutionary distance from the first microorganism in view of molecular phylogeny. More specifically, the examples include microorganisms belonging to the same genus or bacterial strains belonging to the same species. Furthermore, specifically, the examples include microorganisms containing 1000 or more orthologs having a homology in such a degree that amino acid substitutions between two types of genes can be extracted, preferably an identity of 60% or more.
- microorganisms to which the present invention can be applied are not particularly limited, they are desirably industrially useful microorganisms. Examples thereof include, for example, Gram-negative bacteria of the genus Escherichia, Serratia or the like, and Gram-positive bacteria of the genus Corynebacterium, Brevibacterium, Bacillus or the like.
- Examples of the closely relating microorganisms which show a difference in at least one optimum growth condition include, for example, Corynebacterium glutamicum and Corynebacterium efficiens as microorganisms, and which have different optimum growth temperatures.
- Corynebacterium glutamicum is a mesophilic bacterium whereby the optimum growth temperature is 25 to 35° C. Its genome sequence is open to public in the DNA Data Bank Japan (DDBJ), GenBank, EMBL and so forth (accession numbers AX120085, AX127144, AX127145, AX127146, AX127147, AX127148, AX127149, AX127150, AX127151, AX127152 and AX127153).
- Corynebacterium efficiens is a moderately thermophilic bacterium isolated as Corynebacterium thermoaminogenes whereby the optimum growth temperature is 35 to 45° C.
- Japanese Patent Laid-open (Kokai) No. 63-240779, Japanese Patent Publication (Kokoku) No. 7-63383 Japanese Patent Laid-open (Kokai) No. 63-240779, Japanese Patent Publication (Kokoku) No. 7-63383.
- Corynebacterium efficiens Fedou R. et. al., Int. J. Syst. Evol. Microbiol., 52:1127-1131, 2002.
- Corynebacterium efficiens used in the present specification refers to a bacterium previously classified as Corynebacterium thermoaminogenes.
- Specific examples of bacterial strains classified as Corynebacterium efficiens include the Corynebacterium efficiens AJ12340 strain (also referred to as YS-40 strain), AJ12308 strain (also referred to as YS-52 strain), AJ12309 strain (also referred to as YS-155 strain), AJ12310 strain (also referred to as YS-314 strain) and so forth.
- the AJ12340 strain was originally deposited at the Fermentation Research Institute, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (currently the independent administrative institution, International Patent Organism Depository, National Institute of Advanced Industrial Science and Technology, Tsukuba Central 6, 1-1, Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, 305-8566, Japan) on Mar. 13, 1987 and received an accession number of FERM P-9277. Then, the deposit was converted to an international deposit under the provisions of the Budapest Treaty on Oct. 27, 1987, and received an accession number of FERM BP-1539. Furthermore, the AJ12308, AJ12309 and AJ12310 strains were originally deposited at the aforementioned depository on Mar.
- Genes which are orthologs to each other are extracted from the aforementioned two types of closely relating microorganisms.
- the term “gene” used in the present specification means a region in a genome sequence, which encodes or is predicted to encode a protein.
- the term “orthologs” means genes derived from different microorganisms' genomes which have high homology with each other.
- genome sequences of microorganisms used in the present invention already published sequences or newly determined sequences may be used. For example, genome sequences of a large number of microorganisms have been published since that of Haemophilus influenzae was published (Fleischman R. D. et. al., Science, 269:496-512, 1995) and can be utilized. Genome sequences of microorganisms whose sequences have not been published can be determined by methods represented by the whole genome shotgun approach described in the aforementioned report of Fleischman et al.
- Genes which are orthologs to each other are selected as follows, for example. First, sequences predicted to encode proteins are extracted from the genome sequence of each microorganism. Then, each gene sequence is translated into an amino acid sequence and the homology is calculated.
- Programs for predicting genes estimated to encode proteins from a genome sequence of a microorganism include those utilizing the Hidden Markov model. Such programs are frequently used and major examples include Glimmer (Delcher, A. L. et. al., Nucleic Acids Res., 27:4636-4641, 1999), GeneHacker (Yada, T. and Hirosawa, M., DNA Res., 3:336-361, 1996; Yada, T. et. al., Proc. Fifth Int. Conf. Intell. Syst. Mol. Biol., pp. 354-357, 1997), GeneMark.hmm (Lukashin, A. and Borodovsky M., Nucleic Acids Res., 26:1107-1115, 1998; Besemer, J. and Borodovsky M., Nucleic Acids Res., 27:3911-3920, 1997) and so forth.
- Glimmer Delcher, A. L. et. al., Nucleic Acid
- Genes extracted from the genome sequences of two species can be translated into amino acid sequences, and the calculated homologies used to detect orthologs as ORFs having the highest homology with each other (Snel, B., Bork, P. and Huynen, M. A., Nat. Genet., 21:108-110, 1999; Tatusov, R. L., Koonin, E. V. and Lipman, D. J., Science, 278:631-637, 1997; Tejaua, F., Lazcano, A. and Dujon, B., Genome Res., 9:550-557, 1999).
- FASTA Pearson, W.
- the stretcher is a software program for performing alignment on the basis of a principle called global alignment, which outputs overall similarities between two sequences having almost the same lengths as a result, and is suitable for the purpose of the present study.
- genes which are orthologs to each other preferably 1500 or more pairs, more preferably 2000 or more pairs.
- the p-distance (Nei M. et al., Molecular Evolution and Phylogenetics, pp. 17-31, Oxford University Press, New York, 2000) between the orthologous genes is preferably 0.3 or less. If the distance is larger than this value, it becomes more likely that parallel or backward substitutions would be extracted as amino acid substitutions.
- genes which are orthologs to each other preferably have an identity of 60% or more and less than 95% on the amino acid sequence level.
- identity is lower than this range, it becomes difficult to perform the alignment, and it becomes more likely that amino acids will not correspond to each other one-to-one.
- Genes having an identity higher than this range do not necessarily need to be excluded. However, since such genes typically encode proteins with extremely conserved functions, it is highly likely that they do not affect phenotypes.
- amino acid substitutions between an amino acid sequence encoded by a gene of the first microorganism and an amino acid sequence encoded by a gene of the second microorganism are detected.
- Amino acid substitutions present between two genes can be detected as a result of the aforementioned gene alignment.
- the detected amino acid substitutions are compiled and the frequency of each type of amino acid substitution can be calculated.
- a correction is made by subtracting the total number of substitution types which occur from the first microorganism to the second microorganism from the total number of the same substitution type which occur in the reverse direction, or from the second microorganism to the first microorganism,
- substitution of lysine in the second microorganism gene for arginine in the first microorganism gene is subtracted. Specifically, this is performed as follows, for example.
- amino acid substitutions occurring at a higher substitution frequency are identified as the amino acid substitutions involved in the optimum growth condition of the second microorganism.
- the number of amino acid substitutions to be identified is not particularly limited, and is preferably 2 to 10 types, more preferably 2 to 5 types, particularly preferably 2 to 3 types. It is generally known that isoleucine, valine, leucine and methionine are amino acids that are likely to cause mutation among them (Kreil, D. P. et al., Nucleic Acids Res., 29:1608-1615, 2001). Therefore, among amino acid substitutions occurring at a higher substitution frequency, it is preferable to select substitutions occurring at a higher frequency than those of substitutions among isoleucine, valine, leucine and methionine.
- amino acid substitutions are identified as amino acid substitutions involved in the impartation of thermostability of Corynebacterium efficiens to Corynebacterium glutamicum:
- One or more amino acid substitutions identified as described above are introduced into a protein whereby said property is to be modified.
- the objective protein to have the modified property imparted is not particularly limited, and examples thereof include, for example, proteins that preferably function under an optimum growth condition particular to the aforementioned second microorganism.
- proteins may be proteins of the aforementioned first microorganism or proteins of other microorganisms so long as they are proteins of microorganisms having a different optimum growth condition compared with that of the second microorganism.
- One type of amino acid substitution may be introduced at one site or two or more sites.
- a mutation can usually be introduced into a gene encoding the aforementioned protein by a technique utilized in the protein engineering art, such as site-directed mutagenesis, so that a desired amino acid substitution occurs.
- a protein can also be produced by introducing the gene which has a mutation into a host suitable for gene expression utilizing a technique used in protein production based on a gene recombination technique to express a mutant protein having a modified property.
- the produced mutant proteins the aforementioned property is tested, if necessary, to select a protein of which property has been modified as intended.
- a microorganism having a modified property such as thermostability can be obtained by introducing the identified amino acid substitution into a gene on a chromosome of a target microorganism.
- the amino acid substitution can be introduced into the gene on a chromosome by, for example, preparing a gene introduced with a target mutation or a fragment thereof beforehand and substituting the mutant gene for the gene on chromosome on the basis of a gene substitution technique utilizing homologous recombination.
- an amino acid substitution that can impart a desired property can be introduced into a gene encoding a protein so that a property of one or more proteins of the microorganism is modified.
- a protein and microorganism having a modified property can be obtained.
- a protein such as an enzyme that functions at a higher temperature as compared with a wild-type protein or a microorganism having an optimum growth temperature raised can be obtained.
- Increase of culture temperature is considered to be an important technical factor for improving the economy of the industrial production of amino acids by fermentation, in addition to improvement of yield per saccharide, reduction of culture time, improvement of accumulated amino acid concentrations and so forth. That is, the culture is usually performed at an optimum fermentation temperature, and the optimum temperature of Corynebacterium glutamicum is 31.5° C. Since heat is generated by fermentation when the culture is started, the temperature in the culture increases, and amino acid production markedly decreases.
- thermostability a bacterial strain having improved thermostability can be produced by imparting thermostability comparable with that of Corynebacterium efficiens to a protein exhibiting low thermostability in a bacterial strain having improved amino acid productivity such as Corynebacterium glutamicum and further allowing to the bacterial strain to have such a thermostabilized protein, industrial usefulness of the strain will be clearly increased.
- thermostable enzyme or bacterial strain For example, if a thermostable enzyme or bacterial strain is used, the load of temperature control during the reaction is relieved, the reaction can be performed at a high temperature, and therefore, the reaction rate becomes higher. Furthermore, since the reaction can be performed at a high temperature, contamination of other microorganisms can be minimized.
- the method of the present invention can be used to produce a protein or microorganism suitable for a certain type of growth condition other than culture temperature.
- a genomic DNA was extracted from the Corynebacterium efficiens AJ12340 strain by using Bacterial Genome DNA Purification Kit (Advanced Genetic Technologies). The following procedure is described in detail in the reference of Kawarabayashi et al. (Kawarabayashi, Y., et. al., DNA Res., 8:123-140, 2001).
- the genomic DNA of Corynebacterium efficiens was ultrasonicated in three stages of 5, 10 and 20 seconds by using an ultrasonicator, Biorupter (Cosmo Bio), at an output of L.
- the resultant solution was subjected to electrophoresis using an agarose gel, and DNA fragments having sizes of 0.8 to 1.2 kb and 2.0 to 2.5 kb were excised and cloned into the HincII site of pUC118.
- a shotgun library consisting of short (0.8 to 1.2 kb) and long fragments (2.0 to 2.5 kb) was prepared.
- Plasmid DNAs in the aforementioned shotgun library comprising short (0.8 to 1.2 kb) and long fragments (2.0 to 2.5 kb) were prepared by using automatic DNA isolators PI-100 and PI-200 (Kurabo Industries Ltd.). The sequencing reaction was performed by using these plasmid DNAs as templates and ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (PERKIN ELMER) or ABI PRISM BigDye Primer Cycle Sequencing Ready Reaction Kit (PERKIN ELMER). For the short fragment library, each sequence at one end was determined by using M13 forward primer ( ⁇ 21 M13) as a primer.
- M13 forward primer ⁇ 21 M13
- sequences at the both ends were determined by using M13 forward primer ( ⁇ 21 M13) and M13 reverse primer (M13 Reverse).
- PCR System 9600 PERKIN ELMER
- DNA Engine PTC-200 MJ RESEARCH
- Raw data about 70,000 sequences were assembled by using an assembling software program, Phred-Phrap (CodonCode), and the raw data contained in the obtained contigs were assembled again using Sequencer (Gene Codes) to confirm and correct the nucleotide sequences.
- the nucleotide sequences of the gap portions between the contigs were determined by walking the shotgun clones including a long fragment using synthetic primers. Thus, the entire 3.14 million base pair genome sequence of Corynebacterium efficiens was determined. This genome sequence was given accession numbers of BA000035 or AP005214 to AP005224 from the DNA Data Bank of Japan (DDBJ), and was registered and opened to public.
- Genes encoding proteins were predicted by using a gene identification software program, Glimmer, based on the principle of Hidden Markov models (Delcher, A. L. et al., Nucleic Acids Res., 27:4636-4641, 1999). Models used for the gene prediction were created on the basis of the genome sequences of Corynebacterium glutamicum and Corynebacterium efficiens according to the manual of Glimmer. Furthermore, the Shine-Dalgarno sequence (hereinafter, referred to as “SD sequence”) was used to enhance precision of the gene prediction by execution of Glimmer.
- SD sequence Shine-Dalgarno sequence
- the SD sequence is a sequence for binding of mRNA to 16S RNA on a ribosome, which is a translation apparatus, at the time of translation of a gene.
- the used SD sequence was a sequence (5′-AGAAAGAGG-3′) complementary to the sequence at the 3′ end of 16S rRNA of Corynebacterium glutamicum (Amador, J. M. E. et al., Microbiology, 145:915-924, 1999).
- pairwise alignment was performed, in which the gene sequences of Corynebacterium glutamicum and Corynebacterium efficiens were aligned from the N-terminus in consideration of properties of amino acids.
- a software program called stretcher was used for the pairwise alignment.
- the stretcher establishes alignment on the basis of the principle called global alignment, which outputs overall similarities between two sequences having almost the same lengths as a result (Myers, E. and Miller, W., CABIOS, 4:11-17, 1988).
- BLOSUM62 was used, which is commonly used as a matrix expressing the relationships of the same or different types of amino acids as numerical values. According to the alignment results, orthologs were classified into three ranks of those having identities of 95% or more, 60% or more and less than 95%, and less than 60%.
- orthologs having an identity of 95% or more constitute a group of extremely conserved proteins primarily consisting of ribosomal proteins, differences in their thermostability are not expected. Furthermore, because orthologs having an identity of less than 60% include an increased number of amino acid substitutions, it becomes more unlikely that the objective amino acid substitutions can be extracted. Therefore, these orthologs were excluded.
- substitution evaluation index a certain substitution of the reverse direction (for example, mutation from arginine to lysine for mutation from lysine to arginine) can be converted into a single numerical value, and a value for an amino acid showing no substitution can be represented as zero.
- Deviations of amino acid substitutions of orthologs belonging to the rank of identity of 60% or more and less than 95% were aligned in the descending order of the number of substitutions. The result is shown in Table 2.
- substitutions of lysine-arginine, serine-alanine, serine-threonine, and isoleucine-valine were substitutions of the four highest substitution evaluation indices.
- isoleucine, valine, leucine and methionine are amino acids that are easily mutated from one to another (Kreil, D. P. et al., Nucleic Acids Res.
- Thermophilic bacterium Corynebacterium efficiens AJ1234 strain
- the crude enzyme solution was pretreated at 30 to 80° C. for 1, 3, 5 or 10 minutes and reacted with a reaction mixture at 30° C.
- the reaction mixture was prepared by adding the crude enzyme solution to an aqueous solution containing 100 mM Tris-HCl (pH 7.5), 10 mM ATP (pH 7.5), 600 mM hydroxylamine, 600 mM ammonium sulfate, 10 mM magnesium sulfate, 50 mM L-aspartic acid (pH 7.5), and adjusted to the total volume of 500 ⁇ l with sterilized water.
- the reaction was allowed to proceed for a predetermined period of time, and the reaction was terminated by addition of 750 ⁇ l of a reaction terminating solution.
- the reaction terminating solution had a composition of 4% trichloroacetic acid, 10% FeCl 2 and 1.4 N hydrochloric acid.
- the reaction mixture added with the reaction terminating solution was centrifuged at 15,000 rpm for 5 minutes, and the absorbance of the supernatant was measured at a wavelength of 540 nm. This measurement was performed for quantifying color development of hydroxymate produced by the reaction in which L-aspartic acid phosphoric acid salt, ADP and hydroxymate were produced from L-aspartic acid, ATP and hydroxylamine.
- the reaction mixture not containing L-aspartic acid was used as a blank.
- Cells of each strain were cultured in the glutamic acid production medium, and cells in the logarithmic growth phase were collected and washed with 0.85% NaCl.
- the cell suspension was ultrasonicated and centrifuged at 60,000 rpm for 30 minutes, and the resultant supernatant was used as a crude enzyme solution.
- the crude enzyme solution was pretreated beforehand at 60° C. for 1, 3, 5, 10 or 15 minutes and reacted with a reaction mixture at 37° C.
- the reaction mixture was prepared by adding the crude enzyme solution to 50 mM imidazole hydrochloride (pH 7.4), 2 mM aspartate ⁇ -semialdehyde (ASA) and 2 mM sodium pyruvate and adjusted to the total volume of 700 ⁇ l with sterilized water.
- the activity was measured based on the increase in absorbance of the reaction mixture at 270 nm. For this measurement, the absorbance of dihydroxypicolinate non-enzymatically produced from a product of the reaction involving aspartate ⁇ -semialdehyde and pyruvic acid as substrates and catalyzed by dihydrodipicolinate synthase was measured. The reaction mixture not containing sodium pyruvate was used as a blank.
- the crude enzyme solution was pretreated beforehand at 60° C. for 1, 3, 5, 10 or 15 minutes and reacted with a reaction mixture at 37° C.
- the reaction mixture was prepared by adding the crude enzyme solution to 200 mM glycine/potassium chloride buffer (pH 7.5, pH was adjusted with sodium hydroxide), 4 mM mesodiaminopimelic acid and 1 mM NADP, and adjusted to the total volume of 700 ⁇ l with sterilized water.
- the activity was measured based on the increase in absorbance of the reaction mixture at 340 nm. For this measurement, the absorbance of NADPH produced by the reaction involving mesodiaminopimelic acid as a substrate and catalyzed by diaminopimelate dehydrogenase was measured, because the reaction requires NADP + as a coenzyme.
- the reaction mixture not containing mesodiaminopimelic acid was used as a blank.
- Cells of each strain were cultured in the glutamic acid production medium, and the cells in the logarithmic growth phase were collected, washed twice with 50 mM potassium phosphate buffer (pH 7.0), suspended in 50 mM potassium phosphate buffer (pH 7.0) containing 6 mM mercaptoethanol, and disrupted by ultrasonication. The suspension was centrifuged at 15,000 rpm for 30 minutes, and the resultant supernatant was used as a crude enzyme solution.
- the crude enzyme solution was pretreated beforehand at 30 to 80° C. for 1, 3, 5 or 10 minutes and reacted with a reaction mixture at 37° C. for 30 minutes.
- the reaction mixture was prepared by adding the crude enzyme solution to 20 mM diaminopimelic acid and 67 ⁇ M pyridoxal phosphate and adjusted to the total volume of 300 ⁇ l with sterilized water. Sulfuric acid was used to terminate the reaction, and potassium hydroxide was used for neutralization. The enzymatic activity was determined by measuring the amount of lysine produced by the reaction using Biotech Analyzer. The reaction mixture not containing mesodiaminopimelic acid was used as a blank.
- the reaction mixture contained 35 mM Tris-HCl/0.35 mM EDTA (pH 7.5), 1.5 mM manganese sulfate, 0.1 mM NADP and 1.3 mM sodium isocitrate.
- the activity was calculated by measuring the absorbance of NADPH produced by the reaction catalyzed by isocitrate dehydrogenase, because the reaction utilizes NADP + as a coenzyme.
- Cells of each strain were cultured in the glutamic acid production medium, washed three times with a washing buffer, and disrupted by ultrasonication. The suspension was centrifuged at 15,000 rpm for 10 minutes to remove disrupted cell debris.
- the washing buffer contained 100 mM Tris-HCl (pH 8.0), 10 mM magnesium sulfate, 1 mM dithiothreitol (DTT) and 20% glycerol. The supernatant was further centrifuged at 60,000 rpm for 1 hour, and the resultant supernatant was used as a crude enzyme solution.
- the crude enzyme solution was pretreated at 45° C. for 1, 3, 5, 10 or 20 minutes, and then was reacted with 780 ⁇ l of a reaction mixture at 20° C.
- the reaction mixture contained 100 mM Tris-H 2 SO 4 (pH 8.5), 5 mM phosphoenolpyruvate, 10 mM KHCO 3 , 0.1 mM acetyl-CoA, 0.15 mM NADH, 10 mM magnesium sulfate, 10 U of malate dehydrogenase and 0.1 mM dithiothreitol.
- the activity was calculated on the basis of decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm for 2 minutes.
- TES N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid
- pH 7.5 30% glycerol
- the suspension was then centrifuged at 10000 ⁇ g for 30 minutes to obtain a supernatant.
- the resultant supernatant was desalted by using Sephadex G-25, and the resultant solution was used as a crude enzyme solution.
- the crude enzyme solution was pretreated beforehand at 50° C. for 1, 3, 5 or 10 minutes and reacted with a reaction mixture at 37° C.
- the reaction mixture contained 100 mM TES-NaOH (pH 7.7), 5 mM magnesium chloride, 0.2 mM coenzyme A (CoA), 0.3 mM thiamin pyrophosphate (TPP), 1 mM ⁇ -ketoglutaric acid, 3 mM L-cysteine and 1 mM acetylpyridine adenine dinucleotide (APDPN).
- the activity was calculated based on the decrease of APDPN, which is an analogue of NADP used as a coenzyme in the aforementioned reaction, and determined by measuring the absorbance at 365 nm (Usuda Y. et al., Microbiology, 142:3347-3354, 1996).
- the reaction mixture contained 50 mM MOPS-NaOH (pH 7.3), 5 mM DTT, 15 mM magnesium chloride, 1 mM EDTA, 5 mM dithiothreitol, 0.2 mM NADH and 18 U of lactate dehydrogenase (LDH).
- the activity was calculated on the basis of decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm (Reinscheid, D. J. et al., J. Bacteriol., 176:3474-3483, 1994).
- the crude enzyme solution was pretreated at 50° C. for 1, 3, 5 or 10 minutes, and then reacted with a reaction mixture at 37° C.
- the reaction mixture contained 100 mM Tris-HCl (pH 8.2), 0.2 mM NADH, 10 mM magnesium chloride, 2 mM ammonium chloride, 10 mM potassium chloride, 0.2 mM phosphoenolpyruvate, 6.4 mM fructose-6-phosphate, 1 mM ATP and 40 ⁇ g of lactate dehydrogenase/pyruvate kinase (LDH/PK).
- the activity was calculated based on the decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm (Mori M. et al., Agric. Biol. Chem., 51:2671-2678, 1987; Campos G. et al., J. Biol. Chem., 259:6147-6152, 1984).
- the crude enzyme solution was pretreated at 50° C. for 1, 3, 5 or 10 minutes, and then reacted with a reaction mixture at 37° C.
- the reaction mixture contained 100 mM Tris-HCl (pH 8.2), 0.2 mM NADH, 10 mM magnesium chloride, 2 mM ammonium chloride, 10 mM potassium chloride, 0.2 mM phosphoenolpyruvate, 6.4 mM fructose-1-phosphate, 1 mM ATP and 40 ⁇ g of lactate dehydrogenase/pyruvate kinase.
- the activity was calculated based on the decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm.
- Cells of each strain were cultured in the glutamic acid production medium, washed three times with 0.2 M sodium glutamate hydrate and 50 mM Tris-HCl (pH 7.5), and disrupted by ultrasonication. The suspension was centrifuged at 10,000 rpm for 10 minutes, and the resultant supernatant was used as a crude enzyme solution.
- the crude enzyme solution was pretreated at 50° C. for 5 minutes, and then reacted with a reaction mixture at 30° C.
- the reaction mixture contained 0.1 M sodium glutamate hydrate, 0.1 mM 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB), 0.3 mM acetyl-CoA and 0.5 mM oxaloacetic acid.
- the activity was calculated by measuring the increase of the absorbance at 412 nm of thiol-CoA (HS-CoA) mercaptide produced by the reaction (Srera, P. A., Method in Enzymol., 13:11-26, 1969; Eikmanns B. J. et al., Microbiology, 140:1817-1828, 1994).
- the enzyme derived from Corynebacterium efficiens was expected to be more thermostable, whereas if the point was negative, the enzyme derived from Corynebacterium glutamicum was expected to be more thermostable.
- the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 2, that is, positive.
- the experimental result matched the prediction (denoted with ⁇ in Table 2).
- fructose-1-phophate kinase As for fructose-1-phophate kinase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 5, that is, positive. Thus, the experimental result matched the prediction.
- the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 4, that is, positive.
- the experimental result matched the prediction.
- the enzyme derived from Corynebacterium efficiens was more thermostabilized. However, the point was 0, and prediction based on the point was impossible.
- citrate synthase As for citrate synthase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 3, that is, positive. Thus, the experimental result matched the prediction.
- the enzyme derived from Corynebacterium glutamicum was more thermostabilized, and the point was ⁇ 1, that is, negative. Thus, the experimental result matched the prediction.
- dihydrodipicolinate synthase As for dihydrodipicolinate synthase, the enzyme derived from Corynebacterium efficiens was more thermostabilized. However, the point was 0, and thus prediction based on the point was impossible.
- diaminopimelate dehydrogenase the enzyme derived from Corynebacterium glutamicum was more thermostabilized, and the point was ⁇ 2, that is, negative. Thus, the experimental result matched the prediction.
- diaminopimelate decarboxylase As for diaminopimelate decarboxylase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 2, that is, positive. Thus, the experimental result matched the prediction.
- thermostabilization could be correctly predicted for 8 enzymes in 12 enzymes of which enzymatic activities were measured, and could not be predicted for 3 enzymes, whereas the experimental result did not match the point only in one enzyme. Prediction with such a high probability was possible by considering directions of only 3 amino acid substitutions.
- thermostability a property of a protein such as thermostability can be modified by using only information on the primary structure without using information on the secondary structure and tertiary structure of the protein.
- thermostability of proteins produced by mesophilic bacteria or mesophilic bacteria themselves currently being industrially used can be improved.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A method for improving the thermostability of a protein includes introducing, into the protein, two or more amino acid substitutions selected from the group consisting of: (i) substitution of an arginine residue for a lysine residue, (ii) substitution of a threonine residue for a serine residue, and (iii) substitution of an alanine residue for a serine residue.
Description
- This application is a Divisional of, and claims priority under 35 U.S.C. §120 to, U.S. patent application Ser. No. 10/933,280, filed Sep. 3, 2004, which was a Continuation of, and claimed priority under 35 U.S.C. §120 to, International Application No. PCT/JP03/02495, filed Mar. 4, 2003, and claims priority therethrough under 35 U.S.C. §119 to Japanese Patent Application No. 2002-057863, filed Mar. 4, 2002, the entireties of which are incorporated by reference herein.
- 1. Field of the Invention
- The present invention relates to a method for modifying a property of a protein. The present invention also relates to a method for producing a protein which has a modified property, and a method for producing a microorganism which has a modified property. The present invention is useful in the field of microbial industrial production and the like.
- 2. Brief Description of the Related Art
- Proteins and microorganisms which have an activity in an environment which is different from that in environments preferred by usual microorganisms may have advantages over other proteins and microorganisms. For example, proteins which are active at a high temperature, in particular, thermostable enzymes, are advantageous over those that are inactivated at high temperatures because they do not need to be cooled to be active. Usually, such thermostable proteins are often produced by bacteria known as thermophilic bacteria, which can grow at a high temperature. Accordingly, when a thermostable protein is designed, amino acid sequences of corresponding proteins within a group of such thermophilic bacteria are analyzed, and commonly observed characteristics in the amino acid sequences are used for reference in many cases. Alternatively, techniques for analyzing three-dimensional structures of proteins produced by thermophilic bacteria, estimating a structure which imparts thermostability based on this information, and modifying the structure of a non-thermostable protein so as to have such a structure, and the like, are employed. Furthermore, a method has been proposed in which amino acid sequences of evolutionarily corresponding proteins derived from two or more species in an evolutionary tree are compared, and an amino acid sequence of a proper ancestral protein estimated to be a protein of a hyperthermophilic bacterium is estimated to improve the thermostability.
- Objects of the present invention are to provide a method for modifying a property of a protein, for example, thermostability, a method for producing a protein having said modified property, and a method for producing a microorganism having said modified property.
- More specifically, it is an object of the present invention to provide a method for modifying a property of a protein, comprising
- (a) selecting 1000 or more genes from the genome of a first microorganism, and selecting 1000 or more genes from the genome of a second microorganism, wherein the genes from the first microorganism are orthologs to the genes from the second microorganism, and wherein the second microorganism is closely related to the first microorganism, but grows differently under at least one optimum growth condition when compared with the first microorganism,
- (b) comparing an amino acid sequence encoded by a gene from the first microorganism to an amino acid sequence encoded by the orthologous gene from the second microorganism,
- (c) detecting substitutions between the amino acid sequence encoded by a gene from the first microorganism and the amino acid sequence encoded by a gene from the second microorganism for each pair of orthologous genes,
- (d) compiling the detected amino acid substitutions for each amino acid substitution type,
- (e) calculating the frequency of each amino acid substitution type, wherein for each detected amino acid substitution type, a correction is made by subtracting the total number of substitution types which occur from the first microorganism to the second microorganism from the total number of the same substitution type which occurs in the reverse direction, or from the second microorganism to the first microorganism,
- (f) identifying and labelling the amino acid substitutions which occur at a high frequency as amino acid substitutions which are involved in said optimum growth condition, and
- (g) introducing one or more of the amino acid substitutions identified in (f) into the gene encoding the protein to modify a property of the protein.
- It is a further object of the present invention to provide the method as described above, wherein said optimum growth condition is optimum growth temperature, and the property of the protein is thermostability.
- It is a further object of the present invention to provide the method as described above, wherein genes having an identity of 60% or more and less than 95% on the amino acid sequence level are selected as genes which are orthologs to each other.
- It is a further object of the present invention to provide the method as described above, wherein the first microorganism and the second microorganism are coryneform bacteria.
- It is a further object of the present invention to provide the method as described above, wherein the first microorganism is Corynebacterium glutamicum, and the second microorganism is Corynebacterium efficiens.
- It is an object of the present invention to provide a method for improving thermostability of a protein, comprising introducing into said protein two or more amino acid substitutions selected from the group consisting of:
- (i) substitution of an arginine residue for a lysine residue,
- (ii) substitution of a threonine residue for a serine residue, and
- (iii) substitution of an alanine residue for a serine residue.
- It is an object of the present invention to provide a method for producing a protein having a modified property comprising:
- (a) selecting 1000 or more genes from the genome of a first microorganism, and selecting 1000 or more genes from the genome of a second microorganism, wherein the genes from the first microorganism are orthologs to the genes from the second microorganism, and wherein the second microorganism is closely related to the first microorganism, but grows differently under at least one optimum growth condition when compared with the first microorganism,
- (b) comparing an amino acid sequence encoded by a gene from the first microorganism to an amino acid sequence encoded by the orthologous gene from the second microorganism,
- (c) detecting substitutions between the amino acid sequence encoded by a gene from the first microorganism and the amino acid sequence encoded by a gene from the second microorganism for each pair of orthologous genes,
- (d) compiling the detected amino acid substitutions for each amino acid substitution type,
- (e) calculating the frequency of each amino acid substitution type, wherein for each detected amino acid substitution type, a correction is made by subtracting the total number of substitution types which occur from the first microorganism to the second microorganism from the total number of the same substitution type which occurs in the reverse direction, or from the second microorganism to the first microorganism,
- (f) identifying and labelling the amino acid substitutions which occur at a high frequency as amino acid substitutions which are involved in said optimum growth condition, and
- (g) introducing one or more of the amino acid substitutions identified in (f) into the gene encoding the protein to modify a property of the protein,
- (h) introducing said gene obtained in (g) into a suitable host for gene expression to express the protein having a modified property.
- It is a further object of the present invention to provide the method as described above, further comprising the steps of:
- (i) testing the property of the protein obtained in (h), and
- (j) selecting a protein having an improved property relating to said optimum growth condition.
- It is a further object of the present invention to provide the method as described above, wherein said optimum growth condition is optimum growth temperature, and the property of the protein is thermostability.
- It is a further object of the present invention to provide a method for producing a microorganism having a modified property comprising:
- (a) selecting 1000 or more genes from the genome of a first microorganism, and selecting 1000 or more genes from the genome of a second microorganism, wherein the genes from the first microorganism are orthologs to the genes from the second microorganism, and wherein the second microorganism is closely related to the first microorganism, but grows differently under at least one optimum growth condition when compared with the first microorganism,
- (b) comparing an amino acid sequence encoded by a gene from the first microorganism to an amino acid sequence encoded by the orthologous gene from the second microorganism,
- (c) detecting substitutions between the amino acid sequence encoded by a gene from the first microorganism and the amino acid sequence encoded by a gene from the second microorganism for each pair of orthologous genes,
- (d) compiling the detected amino acid substitutions for each amino acid substitution type,
- (e) calculating the frequency of each amino acid substitution type, wherein for each detected amino acid substitution type, a correction is made by subtracting the total number of substitution types which occur from the first microorganism to the second microorganism from the total number of the same substitution type which occurs in the reverse direction, or from the second microorganism to the first microorganism,
- (f) identifying and labelling the amino acid substitutions which occur at a high frequency as amino acid substitutions which are involved in said optimum growth condition, and
- (g) introducing one or more of the amino acid substitutions identified in (f) into a chromosomal DNA of a microorganism to modify a property of said microorganism.
- It is a further object of the present invention to provide the method as described above, wherein said optimum growth condition is optimum growth temperature, and the property of the protein is thermostability.
- The inventors of the present invention assiduously studied in order to achieve the above objects. As a result, they found that by using the genome sequences of closely related microorganisms which show a difference in a certain property and comparing the primary structure information of a large number of proteins, amino acid substitutions contributing to the identified property could be determined. Then, they took note of thermostability as a property of a protein. They concluded that amino acid substitutions contributing to thermostabilization could be predicted by comparing moderately thermophilic bacteria growing at about 55 to 74° C. or bacteria which show an even lower optimum growth temperature, but not hyperthermophilic bacteria which grow at about 75° C. or higher, with closely related bacteria with a clearly lower optimum growth temperature. Furthermore, they confirmed that the amino acid substitutions which might be involved in temperature resistance could be precisely predicted by comparing a large number of amino acid sequences of orthologous genes extracted from the genome sequences of two types of closely related bacteria showing different optimum growth temperatures, that is, bacteria of a thermophilic type and a mesophilic type, and thus accomplished the present invention.
- The method for modifying a property of a protein of the present invention comprises the following steps of:
- (a) selecting 1000 or more genes from the genome of a first microorganism, and selecting 1000 or more genes from the genome of a second microorganism, wherein the genes from the first microorganism are orthologs to the genes from the second microorganism, and wherein the second microorganism is closely related to the first microorganism and but grows under at least one different optimum condition, when compared with the first microorganism,
- (b) comparing an amino acid sequence encoded by a gene from the first microorganism to an amino acid sequence encoded by the orthologous gene from the second microorganism,
- (c) detecting substitutions between the amino acid sequence encoded by a gene from the first microorganism and the amino acid sequence encoded by a gene from the second microorganism for each pair of orthologous genes and
- (d) compiling the detected amino acid substitutions for each amino acid substitution type,
- (e) calculating a frequency of each amino acid substitution type, wherein for each detected amino acid substitution type, a correction is make by subtracting the total number of substitution types which occur from the first microorganism to the second microorganism from the total number of the same substitution type which occurs in the reverse direction, or from the second microorganism to the first microorganism,
- (f) identifying and labelling the amino acid substitutions which occur at a higher frequency as amino acid substitutions which are involved in said optimum growth condition,
- (g) introducing one or more of the amino acid substitutions identified in (f) into the gene encoding the protein to modify a property of the protein.
- In the present invention, the optimum growth condition or optimum conditions for growth means a condition suitable for survival or growth of a microorganism, and examples thereof include optimum growth temperature, optimum growth pH, optimum growth osmotic pressure and so forth. Properties of proteins to be modified by the present invention which correspond to these optimum growth conditions, and examples thereof include thermostability, acid or alkali resistance, halophilism and so forth. The degree of difference between the two chosen microorganims in their optimum growth condition is not particularly limited so long as those of the first microorganism and the second microorganism are different. However, for example, when the condition is growth temperature, the optimum growth temperatures are preferably different by 5° C. or more.
- In the present invention, the two types of closely related microorganisms having a difference in at least one their optimum growth conditions are used as information sources of amino acid substitutions that can impart a desired property to a protein. Examples of the second microorganism closely relating to the first microorganism include microorganisms that have taxonomic properties similar to those of the first microorganism or are at a close evolutionary distance from the first microorganism in view of molecular phylogeny. More specifically, the examples include microorganisms belonging to the same genus or bacterial strains belonging to the same species. Furthermore, specifically, the examples include microorganisms containing 1000 or more orthologs having a homology in such a degree that amino acid substitutions between two types of genes can be extracted, preferably an identity of 60% or more.
- Although microorganisms to which the present invention can be applied are not particularly limited, they are desirably industrially useful microorganisms. Examples thereof include, for example, Gram-negative bacteria of the genus Escherichia, Serratia or the like, and Gram-positive bacteria of the genus Corynebacterium, Brevibacterium, Bacillus or the like.
- Examples of the closely relating microorganisms which show a difference in at least one optimum growth condition include, for example, Corynebacterium glutamicum and Corynebacterium efficiens as microorganisms, and which have different optimum growth temperatures. Corynebacterium glutamicum is a mesophilic bacterium whereby the optimum growth temperature is 25 to 35° C. Its genome sequence is open to public in the DNA Data Bank Japan (DDBJ), GenBank, EMBL and so forth (accession numbers AX120085, AX127144, AX127145, AX127146, AX127147, AX127148, AX127149, AX127150, AX127151, AX127152 and AX127153). Furthermore, Corynebacterium efficiens is a moderately thermophilic bacterium isolated as Corynebacterium thermoaminogenes whereby the optimum growth temperature is 35 to 45° C. (Japanese Patent Laid-open (Kokai) No. 63-240779, Japanese Patent Publication (Kokoku) No. 7-63383). However, it has been proposed to be re-classified as Corynebacterium efficiens (Fudou R. et. al., Int. J. Syst. Evol. Microbiol., 52:1127-1131, 2002). The term Corynebacterium efficiens used in the present specification refers to a bacterium previously classified as Corynebacterium thermoaminogenes. Specific examples of bacterial strains classified as Corynebacterium efficiens include the Corynebacterium efficiens AJ12340 strain (also referred to as YS-40 strain), AJ12308 strain (also referred to as YS-52 strain), AJ12309 strain (also referred to as YS-155 strain), AJ12310 strain (also referred to as YS-314 strain) and so forth.
- The AJ12340 strain was originally deposited at the Fermentation Research Institute, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (currently the independent administrative institution, International Patent Organism Depository, National Institute of Advanced Industrial Science and Technology, Tsukuba Central 6, 1-1, Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, 305-8566, Japan) on Mar. 13, 1987 and received an accession number of FERM P-9277. Then, the deposit was converted to an international deposit under the provisions of the Budapest Treaty on Oct. 27, 1987, and received an accession number of FERM BP-1539. Furthermore, the AJ12308, AJ12309 and AJ12310 strains were originally deposited at the aforementioned depository on Mar. 10, 1987 and received accession numbers of FERM P-9244, FERM P-9245 and FERM P-9246, respectively. Then, the deposits were converted to international deposits under the provisions of the Budapest Treaty on Oct. 27, 1987, and received accession numbers of FERM BP-1540, FERM BP-1541 and FERM BP-1542, respectively.
- Genes which are orthologs to each other are extracted from the aforementioned two types of closely relating microorganisms. The term “gene” used in the present specification means a region in a genome sequence, which encodes or is predicted to encode a protein. The term “orthologs” means genes derived from different microorganisms' genomes which have high homology with each other.
- As genome sequences of microorganisms used in the present invention, already published sequences or newly determined sequences may be used. For example, genome sequences of a large number of microorganisms have been published since that of Haemophilus influenzae was published (Fleischman R. D. et. al., Science, 269:496-512, 1995) and can be utilized. Genome sequences of microorganisms whose sequences have not been published can be determined by methods represented by the whole genome shotgun approach described in the aforementioned report of Fleischman et al.
- Genes which are orthologs to each other are selected as follows, for example. First, sequences predicted to encode proteins are extracted from the genome sequence of each microorganism. Then, each gene sequence is translated into an amino acid sequence and the homology is calculated.
- Programs for predicting genes estimated to encode proteins from a genome sequence of a microorganism include those utilizing the Hidden Markov model. Such programs are frequently used and major examples include Glimmer (Delcher, A. L. et. al., Nucleic Acids Res., 27:4636-4641, 1999), GeneHacker (Yada, T. and Hirosawa, M., DNA Res., 3:336-361, 1996; Yada, T. et. al., Proc. Fifth Int. Conf. Intell. Syst. Mol. Biol., pp. 354-357, 1997), GeneMark.hmm (Lukashin, A. and Borodovsky M., Nucleic Acids Res., 26:1107-1115, 1998; Besemer, J. and Borodovsky M., Nucleic Acids Res., 27:3911-3920, 1997) and so forth.
- Genes extracted from the genome sequences of two species can be translated into amino acid sequences, and the calculated homologies used to detect orthologs as ORFs having the highest homology with each other (Snel, B., Bork, P. and Huynen, M. A., Nat. Genet., 21:108-110, 1999; Tatusov, R. L., Koonin, E. V. and Lipman, D. J., Science, 278:631-637, 1997; Tejaua, F., Lazcano, A. and Dujon, B., Genome Res., 9:550-557, 1999). To examine orthologs, commonly used homology search methods such as FASTA (Lipman, D. J. and Pearson, W. R., Science, 227:1435-1441, 1985) and Smith-Waterman (Smith, T. F. and Waterman, M. S., J. Mol. Biol., 147:195-197, 1981) are available. The most commonly used method is BLASTP (Altschul, F. S., Maddenm T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. and Lipman, D. J., Nucleic Acids Res., 25:3389-3402, 1997).
- To compare two amino acid sequences, alignment of the amino acid sequences is performed in which the sequences are aligned in consideration of properties of amino acids. As an alignment technique, CLUSTAL W (Thompson, J. D., Higgins, D. G. and Gibson, T. J., Nucleic Acids Res., 22:4673-4680, 1994) is well known. However, to align two sequences by comparing them from the N-terminus, a technique called pairwise alignment is effective, and software programs therefor such as needle (Needleman, S. B. and Wunsch, C. D., J. Mol. Biol., 48:443-453, 1970), matcher (Huang, X. and Miller, W., Adv. Appl. Math., 12:373-381, 1991) and stretcher (Myers, E. and Miller, W., CABIOS, 4:11-17, 1988) are available. The stretcher is a software program for performing alignment on the basis of a principle called global alignment, which outputs overall similarities between two sequences having almost the same lengths as a result, and is suitable for the purpose of the present study.
- In the present invention, it is preferable to select 1000 or more genes from each microorganism, resulting in pairs of genes which are orthologs to each other, preferably 1500 or more pairs, more preferably 2000 or more pairs. Furthermore, the p-distance (Nei M. et al., Molecular Evolution and Phylogenetics, pp. 17-31, Oxford University Press, New York, 2000) between the orthologous genes is preferably 0.3 or less. If the distance is larger than this value, it becomes more likely that parallel or backward substitutions would be extracted as amino acid substitutions. Furthermore, genes which are orthologs to each other preferably have an identity of 60% or more and less than 95% on the amino acid sequence level. If identity is lower than this range, it becomes difficult to perform the alignment, and it becomes more likely that amino acids will not correspond to each other one-to-one. Genes having an identity higher than this range do not necessarily need to be excluded. However, since such genes typically encode proteins with extremely conserved functions, it is highly likely that they do not affect phenotypes.
- For each pair of orthologous genes selected as described above, amino acid substitutions between an amino acid sequence encoded by a gene of the first microorganism and an amino acid sequence encoded by a gene of the second microorganism are detected. Amino acid substitutions present between two genes can be detected as a result of the aforementioned gene alignment. On the basis of the results, the detected amino acid substitutions are compiled and the frequency of each type of amino acid substitution can be calculated. Subsequently, for each detected amino acid substitution type, a correction is made by subtracting the total number of substitution types which occur from the first microorganism to the second microorganism from the total number of the same substitution type which occur in the reverse direction, or from the second microorganism to the first microorganism,
- That is, from a number of particular substitutions (for example, substitution of lysine in the second microorganism gene for arginine in the first microorganism gene), the number of substitutions in the reverse direction to the particular substitution (substitution of arginine in the second microorganism gene for lysine in the first microorganism gene) is subtracted. Specifically, this is performed as follows, for example.
- On the assumption that amino acids substitutions occur as a one-to-one amino acid correspondence, the alignment results are compiled as a matrix of 20 rows and 20 columns comprising the number of amino acid substitutions for all the 20 types of amino acids. This is assumed as a mathematical matrix (hereinafter, referred to as “A”), and a transposed matrix is created to simultaneously evaluate the reverse amino acid substitutions (hereinafter, referred to as “A−1”). Then, (matrix A−transposed matrix A−1)/2 is calculated (hereinafter, this calculation result will be referred to as “substitution evaluation index”).
- Among the amino acid substitutions extracted as described above, amino acid substitutions occurring at a higher substitution frequency (having a higher substitution evaluation index) are identified as the amino acid substitutions involved in the optimum growth condition of the second microorganism. The number of amino acid substitutions to be identified is not particularly limited, and is preferably 2 to 10 types, more preferably 2 to 5 types, particularly preferably 2 to 3 types. It is generally known that isoleucine, valine, leucine and methionine are amino acids that are likely to cause mutation among them (Kreil, D. P. et al., Nucleic Acids Res., 29:1608-1615, 2001). Therefore, among amino acid substitutions occurring at a higher substitution frequency, it is preferable to select substitutions occurring at a higher frequency than those of substitutions among isoleucine, valine, leucine and methionine.
- As described above, the following amino acid substitutions, for example, are identified as amino acid substitutions involved in the impartation of thermostability of Corynebacterium efficiens to Corynebacterium glutamicum:
- (i) Substitution of an arginine residue for a lysine residue
- (ii) Substitution of a threonine residue for a serine residue
- (iii) Substitution of an alanine residue for a serine residue.
- One or more amino acid substitutions identified as described above are introduced into a protein whereby said property is to be modified. The objective protein to have the modified property imparted is not particularly limited, and examples thereof include, for example, proteins that preferably function under an optimum growth condition particular to the aforementioned second microorganism. Such proteins may be proteins of the aforementioned first microorganism or proteins of other microorganisms so long as they are proteins of microorganisms having a different optimum growth condition compared with that of the second microorganism. One type of amino acid substitution may be introduced at one site or two or more sites.
- To introduce an amino acid substitution into an objective protein, a mutation can usually be introduced into a gene encoding the aforementioned protein by a technique utilized in the protein engineering art, such as site-directed mutagenesis, so that a desired amino acid substitution occurs. Furthermore, such a protein can also be produced by introducing the gene which has a mutation into a host suitable for gene expression utilizing a technique used in protein production based on a gene recombination technique to express a mutant protein having a modified property. As for the produced mutant proteins, the aforementioned property is tested, if necessary, to select a protein of which property has been modified as intended.
- Furthermore, a microorganism having a modified property such as thermostability can be obtained by introducing the identified amino acid substitution into a gene on a chromosome of a target microorganism. The amino acid substitution can be introduced into the gene on a chromosome by, for example, preparing a gene introduced with a target mutation or a fragment thereof beforehand and substituting the mutant gene for the gene on chromosome on the basis of a gene substitution technique utilizing homologous recombination.
- As methods for isolation of gene, digestion and ligation of DNA, transformation and so forth required for the aforementioned procedures, usual methods known to those skilled in the art can be used. Such methods are described in Sambrook, J., Fritsch, E. F. and Maniatis, T. “Molecular Cloning A Laboratory Manual, Second Edition”, Cold Spring Harbor Laboratory Press (1989) and so forth.
- To obtain a microorganism having a modified property, an amino acid substitution that can impart a desired property can be introduced into a gene encoding a protein so that a property of one or more proteins of the microorganism is modified.
- As described above, a protein and microorganism having a modified property can be obtained. Specifically, for example, a protein such as an enzyme that functions at a higher temperature as compared with a wild-type protein or a microorganism having an optimum growth temperature raised can be obtained. Increase of culture temperature is considered to be an important technical factor for improving the economy of the industrial production of amino acids by fermentation, in addition to improvement of yield per saccharide, reduction of culture time, improvement of accumulated amino acid concentrations and so forth. That is, the culture is usually performed at an optimum fermentation temperature, and the optimum temperature of Corynebacterium glutamicum is 31.5° C. Since heat is generated by fermentation when the culture is started, the temperature in the culture increases, and amino acid production markedly decreases. Therefore, a cooling unit is necessary to maintain the culture broth at optimum temperature. On the other hand, if the culture temperature can be elevated, the energy necessary for cooling can be reduced, and furthermore, the cooling power of the unit can be reduced. Therefore, if a bacterial strain having improved thermostability can be produced by imparting thermostability comparable with that of Corynebacterium efficiens to a protein exhibiting low thermostability in a bacterial strain having improved amino acid productivity such as Corynebacterium glutamicum and further allowing to the bacterial strain to have such a thermostabilized protein, industrial usefulness of the strain will be clearly increased. For example, if a thermostable enzyme or bacterial strain is used, the load of temperature control during the reaction is relieved, the reaction can be performed at a high temperature, and therefore, the reaction rate becomes higher. Furthermore, since the reaction can be performed at a high temperature, contamination of other microorganisms can be minimized.
- Furthermore, the method of the present invention can be used to produce a protein or microorganism suitable for a certain type of growth condition other than culture temperature.
- Hereafter, the present invention will be explained more specifically by way of the following non-limiting examples.
- Preparation of the Genomic DNA and Preparation of Shotgun Clones
- A genomic DNA was extracted from the Corynebacterium efficiens AJ12340 strain by using Bacterial Genome DNA Purification Kit (Advanced Genetic Technologies). The following procedure is described in detail in the reference of Kawarabayashi et al. (Kawarabayashi, Y., et. al., DNA Res., 8:123-140, 2001). The genomic DNA of Corynebacterium efficiens was ultrasonicated in three stages of 5, 10 and 20 seconds by using an ultrasonicator, Biorupter (Cosmo Bio), at an output of L. The resultant solution was subjected to electrophoresis using an agarose gel, and DNA fragments having sizes of 0.8 to 1.2 kb and 2.0 to 2.5 kb were excised and cloned into the HincII site of pUC118. As described above, a shotgun library consisting of short (0.8 to 1.2 kb) and long fragments (2.0 to 2.5 kb) was prepared.
- (2) Sequencing of Shotgun Library
- Plasmid DNAs in the aforementioned shotgun library comprising short (0.8 to 1.2 kb) and long fragments (2.0 to 2.5 kb) were prepared by using automatic DNA isolators PI-100 and PI-200 (Kurabo Industries Ltd.). The sequencing reaction was performed by using these plasmid DNAs as templates and ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (PERKIN ELMER) or ABI PRISM BigDye Primer Cycle Sequencing Ready Reaction Kit (PERKIN ELMER). For the short fragment library, each sequence at one end was determined by using M13 forward primer (−21 M13) as a primer. For the long fragment library, sequences at the both ends were determined by using M13 forward primer (−21 M13) and M13 reverse primer (M13 Reverse). PCR System 9600 (PERKIN ELMER) or DNA Engine PTC-200 (MJ RESEARCH) was used for the reaction. The nucleotide sequences of the sequencing reaction products were analyzed by using ABI PRISM 377 DNA Sequencer.
- (3) Assembling and Sequencing of Gap Region
- Raw data about 70,000 sequences were assembled by using an assembling software program, Phred-Phrap (CodonCode), and the raw data contained in the obtained contigs were assembled again using Sequencer (Gene Codes) to confirm and correct the nucleotide sequences. The nucleotide sequences of the gap portions between the contigs were determined by walking the shotgun clones including a long fragment using synthetic primers. Thus, the entire 3.14 million base pair genome sequence of Corynebacterium efficiens was determined. This genome sequence was given accession numbers of BA000035 or AP005214 to AP005224 from the DNA Data Bank of Japan (DDBJ), and was registered and opened to public.
- Sequence Information of Corynebacterium glutamicum
- As the genome sequence of the mesophilic bacterium, Corynebacterium glutamicum, the nucleotide sequences of the Corynebacterium glutamicum ATCC 13032 strain registered with accession numbers of AX120085, AX127144, AX127145, AX127146, AX127147, AX127148, AX127149, AX127150, AX127151, AX127152 and AX127153 at the DNA Data Bank Japan were used.
- (2) Prediction of Genes Encoding Proteins
- Genes encoding proteins were predicted by using a gene identification software program, Glimmer, based on the principle of Hidden Markov models (Delcher, A. L. et al., Nucleic Acids Res., 27:4636-4641, 1999). Models used for the gene prediction were created on the basis of the genome sequences of Corynebacterium glutamicum and Corynebacterium efficiens according to the manual of Glimmer. Furthermore, the Shine-Dalgarno sequence (hereinafter, referred to as “SD sequence”) was used to enhance precision of the gene prediction by execution of Glimmer. The SD sequence is a sequence for binding of mRNA to 16S RNA on a ribosome, which is a translation apparatus, at the time of translation of a gene. The used SD sequence was a sequence (5′-AGAAAGAGG-3′) complementary to the sequence at the 3′ end of 16S rRNA of Corynebacterium glutamicum (Amador, J. M. E. et al., Microbiology, 145:915-924, 1999).
- (3) Extraction of Orthologs of Corynebacterium glutamicum and Corynebacterium efficiens
- Pairs of genes that had the highest homology with each other among the extracted genes encoding proteins were assumed as orthologs (Snel, B. et al., Science, 278:631-637,1997; Tejaua, F. et al., Genome Res., 9:550-557, 1999). Specifically, the nucleotide sequences of the genes encoding proteins were translated into amino acid sequences, and pairs of genes that showed the highest score for each other as a result of execution of BLASTP (Altschul, F. S. et al., Nucleic Acids Res., 25:3389-3402, 1997), which is the most commonly used for homology search, were selected as orthologs. BLASTP was executed under the default conditions using BLOSUM62, which is commonly used as a matrix. 2178 genes were extracted and identified as orthologs between the genomes of Corynebacterium glutamicum and Corynebacterium efficiens.
- (4) Extraction of Amino Acid Substitutions between Orthologs
- To compare the orthologs, pairwise alignment was performed, in which the gene sequences of Corynebacterium glutamicum and Corynebacterium efficiens were aligned from the N-terminus in consideration of properties of amino acids. A software program called stretcher was used for the pairwise alignment. The stretcher establishes alignment on the basis of the principle called global alignment, which outputs overall similarities between two sequences having almost the same lengths as a result (Myers, E. and Miller, W., CABIOS, 4:11-17, 1988). As an index for considering properties of amino acids at the time of the alignment, BLOSUM62 was used, which is commonly used as a matrix expressing the relationships of the same or different types of amino acids as numerical values. According to the alignment results, orthologs were classified into three ranks of those having identities of 95% or more, 60% or more and less than 95%, and less than 60%.
- Because orthologs having an identity of 95% or more constitute a group of extremely conserved proteins primarily consisting of ribosomal proteins, differences in their thermostability are not expected. Furthermore, because orthologs having an identity of less than 60% include an increased number of amino acid substitutions, it becomes more unlikely that the objective amino acid substitutions can be extracted. Therefore, these orthologs were excluded.
- On the other hand, when an value called p-distance (Nei M. et al., Molecular Evolution and Phylogenetics, pp. 17-31, Oxford University Press, New York, 2000) was calculated for orthologs having an identity of 60% or more and less than 95%, a result of 0.20 was obtained. It is thought that when this p-distance value is less than 0.3, it is unnecessary to consider the possibility that different mutations may occur at the same site, or a mutation may occur twice or more at the same site after differentiation of species. Because orthologs having an identity of less than 60% have a p-distance of 0.40, exclusion of orthologs having an identity less than 60% is considered appropriate. For the above reasons, 1430 orthologs having an identity of 60% or more and less than 95% were used for the analysis of amino acid substitutions. The results of the alignment were compiled as a matrix of the numbers of the amino acid
- substitutions for all the amino acids on the assumption that amino acid substitutions are in one-to-one amino acid correspondence (Table 1). In Table 1, the amino acids of Corynebacterium glutamicum are shown in the vertical direction, and the amino acids of Corynebacterium efficiens are shown in the horizontal direction. For example, when a proline in Corynebacterium efficiens gene is substituted for an alanine residue in a gene sequence of Corynebacterium glutamicum, this substitution is entered in the cell at the intersection of the first row and the thirteenth column.
- The aforementioned matrix was assumed as a mathematical matrix (hereinafter, referred to as “A”), and (matrix A−transposed matrix A−1)/2 was calculated to evaluate amino acid substitutions of the reverse direction at the same time (hereinafter, this calculation result is referred to as “substitution evaluation index”). By this procedure, a certain substitution of the reverse direction (for example, mutation from arginine to lysine for mutation from lysine to arginine) can be converted into a single numerical value, and a value for an amino acid showing no substitution can be represented as zero. The calculation results obtained as described above were aligned in the descending order of the substitution evaluation index.
-
TABLE 1 Numbers of all amino acid substitutions in orthologs having homology of 60% A C D E F G H I K L M 50566 96 648 1244 90 1316 146 259 283 463 134 73 3068 3 9 22 37 4 19 4 25 7 679 2 27982 3055 13 794 187 20 114 38 13 1428 3 3113 28520 9 560 170 53 348 103 42 135 20 18 15 17176 49 126 245 7 868 100 1265 28 581 314 28 43863 62 28 69 64 18 149 5 149 147 54 97 9466 23 72 78 14 385 15 35 66 187 56 38 24516 35 2191 414 578 8 284 593 11 248 157 54 12938 123 73 494 35 44 105 596 92 124 1642 72 48877 1095 160 4 13 25 71 28 19 331 36 1170 10591 396 13 1321 373 22 557 416 51 273 43 28 656 6 199 235 15 148 51 21 71 76 20 528 6 296 1121 20 248 342 42 415 190 74 301 26 113 195 23 238 295 37 664 173 23 3378 109 682 659 58 1013 173 81 215 139 67 1603 40 415 510 50 313 126 353 235 263 182 1485 48 101 265 174 129 50 3585 65 1529 366 27 8 3 4 67 29 17 6 0 58 9 43 16 20 16 650 22 307 22 9 63 13 N P Q R S T V W Y 241 1019 475 536 2372 1763 1634 28 37 4 5 6 34 86 38 55 0 12 747 237 283 140 447 427 91 2 24 255 406 1096 460 419 641 321 5 13 18 41 26 52 75 78 259 82 876 263 163 100 227 610 247 142 19 12 221 74 299 443 120 156 54 5 178 33 69 57 94 91 435 4332 18 31 312 188 727 2855 320 600 136 14 16 39 167 219 306 126 356 1626 71 95 15 30 57 58 32 153 410 15 15 12726 123 273 333 708 678 88 5 48 36 25111 122 156 297 254 121 5 15 192 240 13003 978 237 420 157 8 26 137 139 372 29928 229 322 92 27 32 623 623 353 525 23062 2623 264 22 48 386 395 313 423 1723 26670 897 12 27 52 197 136 182 177 994 38327 25 38 0 6 3 40 12 13 26 7589 32 30 16 21 47 38 31 49 58 11115 - (5) Narrowing of the Amino acid Substitutions Involved in Thermostability
- Deviations of amino acid substitutions of orthologs belonging to the rank of identity of 60% or more and less than 95% were aligned in the descending order of the number of substitutions. The result is shown in Table 2. When they are described in the order of Corynebacterium glutamicum-Corynebacterium efficiens, substitutions of lysine-arginine, serine-alanine, serine-threonine, and isoleucine-valine were substitutions of the four highest substitution evaluation indices. Among these, it is known that isoleucine, valine, leucine and methionine are amino acids that are easily mutated from one to another (Kreil, D. P. et al., Nucleic Acids Res. 29: 1608-1615, 2001). From the above, the mutation patterns of the highest three substitution evaluation indices, which showed greater directivity than the mutation from isoleucine to valine, were predicted to be the amino acid substitutions involved in the higher thermostability of Corynebacterium efficiens in comparison with Corynebacterium glutamicum.
-
TABLE 2 Amino acid substitutions of the highest 10 substitution evaluation indices in orthologs having identity of 60 to 95% C. glutamicum C. efficiens Substitution evaluation index Lys Arg 1095.5 Ser Ala 503 Ser Thr 450 Ile Val 373.5 Gln Arg 303 Asn Asp 287 Ile Leu 274.5 Ser Gly 201.5 Lys Thr 182.5 Ala Pro 181.5 - <1> Bacterial Strains Used
- Mesophilic bacterium: Corynebacterium glutamicum ATCC 13869 strain
- Thermophilic bacterium: Corynebacterium efficiens AJ1234 strain
- <2> Media
- [Glutamic Acid Production Medium]
- 80 g/l of glucose, 1 g/l of KH2PO4, 0.4 g/l of magnesium sulfate, 480 mg/l of soybean hydrolysate, 200 μg/l of vitamin B1-HCl, 300 μg/l biotin, pH 8.0. pH was adjusted with potassium hydroxide.
- [Medium for Measurement of Isocitrate Lyase Activity]
- 4% of glucose or acetic acid, 5 g/l of ammonium sulfate, 5 g/l of urea, 0.5 g/l of KH2PO4, 0.5 g/l of K2HPO4, 20.9 g/l of 3-[N-morpholino]propanesulfonic acid (MOPS), 0.25 g/l of magnesium sulfate heptahydrate, 10 mM of calcium chloride heptahydrate, 0.2 mg/l of copper sulfate heptahydrate, 0.2 mg/l of biotin, 10 mg/l of manganese sulfate heptahydrate, 10 mg/l of iron sulfate heptahydrate, 1 mg/l of zinc sulfate heptahydrate, pH 6.5. pH was adjusted with potassium hydroxide.
- [CM2G Medium]
- 20 g/l of polypeptone, 20 g/l of yeast extract, 5 g/l of sodium chloride, 20 g/l of glucose, pH 7.0. pH was adjusted with sodium hydroxide.
- All the media were sterilized at 120° C. for 20 minutes.
- <3> Measurement of Enzymatic Activity
- Measurement of thermostability of aspartate kinase
- Cells of each strain were cultured in the glutamic acid production medium, collected and then washed with 0.02 M KH2PO4 (pH 6.75)/0.03 M β-mercaptoethanol. Then, the cells were disrupted by ultrasonication and centrifuged at 33,000 rpm for 1 hour. Ammonium sulfate was added to the obtained supernatant to 80% saturation, and precipitates were obtained by centrifugation. The obtained precipitates were dissolved in 20 mM KH2PO4 (pH 6.75)/30 mM β-mercaptoethanol and used as a crude enzyme solution.
- The crude enzyme solution was pretreated at 30 to 80° C. for 1, 3, 5 or 10 minutes and reacted with a reaction mixture at 30° C. The reaction mixture was prepared by adding the crude enzyme solution to an aqueous solution containing 100 mM Tris-HCl (pH 7.5), 10 mM ATP (pH 7.5), 600 mM hydroxylamine, 600 mM ammonium sulfate, 10 mM magnesium sulfate, 50 mM L-aspartic acid (pH 7.5), and adjusted to the total volume of 500 μl with sterilized water. The reaction was allowed to proceed for a predetermined period of time, and the reaction was terminated by addition of 750 μl of a reaction terminating solution. The reaction terminating solution had a composition of 4% trichloroacetic acid, 10% FeCl2 and 1.4 N hydrochloric acid. The reaction mixture added with the reaction terminating solution was centrifuged at 15,000 rpm for 5 minutes, and the absorbance of the supernatant was measured at a wavelength of 540 nm. This measurement was performed for quantifying color development of hydroxymate produced by the reaction in which L-aspartic acid phosphoric acid salt, ADP and hydroxymate were produced from L-aspartic acid, ATP and hydroxylamine. The reaction mixture not containing L-aspartic acid was used as a blank.
- (2) Measurement of Thermostability of Dihydrodipicolinate Synthase
- Cells of each strain were cultured in the glutamic acid production medium, and cells in the logarithmic growth phase were collected and washed with 0.85% NaCl. The cell suspension was ultrasonicated and centrifuged at 60,000 rpm for 30 minutes, and the resultant supernatant was used as a crude enzyme solution.
- The crude enzyme solution was pretreated beforehand at 60° C. for 1, 3, 5, 10 or 15 minutes and reacted with a reaction mixture at 37° C. The reaction mixture was prepared by adding the crude enzyme solution to 50 mM imidazole hydrochloride (pH 7.4), 2 mM aspartate β-semialdehyde (ASA) and 2 mM sodium pyruvate and adjusted to the total volume of 700 μl with sterilized water.
- The activity was measured based on the increase in absorbance of the reaction mixture at 270 nm. For this measurement, the absorbance of dihydroxypicolinate non-enzymatically produced from a product of the reaction involving aspartate β-semialdehyde and pyruvic acid as substrates and catalyzed by dihydrodipicolinate synthase was measured. The reaction mixture not containing sodium pyruvate was used as a blank.
- (3) Measurement of Thermostability of Diaminopimelate Dehydrogenase
- Cells of each strain were cultured in the glutamic acid production medium, and cells in the logarithmic growth phase were collected, washed twice with 0.2% potassium chloride, and suspended in 40 mM potassium phosphate buffer (pH 7.5). The suspension was ultrasonicated and centrifuged at 15,000 rpm for 30 minutes. The resultant supernatant was used as a crude enzyme solution.
- The crude enzyme solution was pretreated beforehand at 60° C. for 1, 3, 5, 10 or 15 minutes and reacted with a reaction mixture at 37° C. The reaction mixture was prepared by adding the crude enzyme solution to 200 mM glycine/potassium chloride buffer (pH 7.5, pH was adjusted with sodium hydroxide), 4 mM mesodiaminopimelic acid and 1 mM NADP, and adjusted to the total volume of 700 μl with sterilized water.
- The activity was measured based on the increase in absorbance of the reaction mixture at 340 nm. For this measurement, the absorbance of NADPH produced by the reaction involving mesodiaminopimelic acid as a substrate and catalyzed by diaminopimelate dehydrogenase was measured, because the reaction requires NADP+ as a coenzyme. The reaction mixture not containing mesodiaminopimelic acid was used as a blank.
- (4) Measurement of Thermostability of Diaminopimelate Decarboxylase
- Cells of each strain were cultured in the glutamic acid production medium, and the cells in the logarithmic growth phase were collected, washed twice with 50 mM potassium phosphate buffer (pH 7.0), suspended in 50 mM potassium phosphate buffer (pH 7.0) containing 6 mM mercaptoethanol, and disrupted by ultrasonication. The suspension was centrifuged at 15,000 rpm for 30 minutes, and the resultant supernatant was used as a crude enzyme solution.
- The crude enzyme solution was pretreated beforehand at 30 to 80° C. for 1, 3, 5 or 10 minutes and reacted with a reaction mixture at 37° C. for 30 minutes. The reaction mixture was prepared by adding the crude enzyme solution to 20 mM diaminopimelic acid and 67 μM pyridoxal phosphate and adjusted to the total volume of 300 μl with sterilized water. Sulfuric acid was used to terminate the reaction, and potassium hydroxide was used for neutralization. The enzymatic activity was determined by measuring the amount of lysine produced by the reaction using Biotech Analyzer. The reaction mixture not containing mesodiaminopimelic acid was used as a blank.
- (5) Measurement of Thermostability of Isocitrate Dehydrogenase
- Cells of each strain were cultured in the glutamic acid production medium, washed three times with 50 mM Tris-HCl (pH 7.5), and disrupted by ultrasonication. The suspension was centrifuged at 15,000 rpm for 10 minutes, and the resultant supernatant was used as a crude enzyme solution. In a volume of 20 μl of the crude enzyme solution pretreated beforehand at 45° C. for 1, 3, 5, 10 or 15 minutes was reacted with 780 μl of a reaction mixture at 30° C. The reaction mixture contained 35 mM Tris-HCl/0.35 mM EDTA (pH 7.5), 1.5 mM manganese sulfate, 0.1 mM NADP and 1.3 mM sodium isocitrate. The activity was calculated by measuring the absorbance of NADPH produced by the reaction catalyzed by isocitrate dehydrogenase, because the reaction utilizes NADP+ as a coenzyme.
- (6) Measurement of Thermostability of Aconitase
- Cells of each strain were cultured in the glutamic acid production medium, washed three times with 50 mM Tris-HCl (pH 7.5), and disrupted by ultrasonication. The suspension was centrifuged at 15,000 rpm for 10 minutes, and the obtained supernatant was used as a crude enzyme solution. In a volume of 20 μl, the crude enzyme solution was pretreated at 50° C. for 1, 3, 5 or 10 minutes, and then was reacted with 780 μl of a reaction mixture at 30° C. The reaction mixture contained 20 mM Tris-HCl (pH 7.5), 50 mM sodium chloride and 20 mM trisodium isocitrate. The activity was calculated by measuring the absorbance at 240 nm originated from cis-aconitate produced by the reaction.
- (7) Measurement of Thermostability of Phosphoenolpyruvate Carboxylase
- Cells of each strain were cultured in the glutamic acid production medium, washed three times with a washing buffer, and disrupted by ultrasonication. The suspension was centrifuged at 15,000 rpm for 10 minutes to remove disrupted cell debris. The washing buffer contained 100 mM Tris-HCl (pH 8.0), 10 mM magnesium sulfate, 1 mM dithiothreitol (DTT) and 20% glycerol. The supernatant was further centrifuged at 60,000 rpm for 1 hour, and the resultant supernatant was used as a crude enzyme solution.
- In an amount of 20 μl, the crude enzyme solution was pretreated at 45° C. for 1, 3, 5, 10 or 20 minutes, and then was reacted with 780 μl of a reaction mixture at 20° C. The reaction mixture contained 100 mM Tris-H2SO4 (pH 8.5), 5 mM phosphoenolpyruvate, 10 mM KHCO3, 0.1 mM acetyl-CoA, 0.15 mM NADH, 10 mM magnesium sulfate, 10 U of malate dehydrogenase and 0.1 mM dithiothreitol. The activity was calculated on the basis of decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm for 2 minutes.
- (8) Measurement of Thermostability of 2-Oxoglutarate Dehydrogenase
- Cells of each strain were cultured in the glutamic acid production medium, washed twice with 0.2% potassium chloride, suspended in a solution containing 100 mM N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES)-NaOH (pH 7.5) and 30% glycerol, and disrupted by ultrasonication. The suspension was then centrifuged at 10000×g for 30 minutes to obtain a supernatant. The resultant supernatant was desalted by using Sephadex G-25, and the resultant solution was used as a crude enzyme solution.
- The crude enzyme solution was pretreated beforehand at 50° C. for 1, 3, 5 or 10 minutes and reacted with a reaction mixture at 37° C. The reaction mixture contained 100 mM TES-NaOH (pH 7.7), 5 mM magnesium chloride, 0.2 mM coenzyme A (CoA), 0.3 mM thiamin pyrophosphate (TPP), 1 mM α-ketoglutaric acid, 3 mM L-cysteine and 1 mM acetylpyridine adenine dinucleotide (APDPN). The activity was calculated based on the decrease of APDPN, which is an analogue of NADP used as a coenzyme in the aforementioned reaction, and determined by measuring the absorbance at 365 nm (Usuda Y. et al., Microbiology, 142:3347-3354, 1996).
- (9) Measurement of Thermostability of Isocitrate Lyase
- Cells of each strain were cultured in the medium for measurement of isocitrate lyase activity, washed twice with 50 mM Tris-HCl (pH 7.3), and disrupted by ultrasonication. The suspension was centrifuged at 13,000×g for 30 minutes, and the resultant supernatant was used as a crude enzyme solution. The crude enzyme solution was pretreated at 50° C. for 5 minutes and then reacted with a reaction mixture at 37° C. The reaction mixture contained 50 mM MOPS-NaOH (pH 7.3), 5 mM DTT, 15 mM magnesium chloride, 1 mM EDTA, 5 mM dithiothreitol, 0.2 mM NADH and 18 U of lactate dehydrogenase (LDH). The activity was calculated on the basis of decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm (Reinscheid, D. J. et al., J. Bacteriol., 176:3474-3483, 1994).
- (10) Measurement of Thermostability of Phosphofructokinase
- Cells of each strain were cultured in the CM2G medium, washed twice with 0.1 M Tris-HCl (pH 7.5), and disrupted by ultrasonication. Then, the suspension was centrifuged at 13,000×g for 30 minutes, and the resultant supernatant was used as a crude enzyme solution.
- The crude enzyme solution was pretreated at 50° C. for 1, 3, 5 or 10 minutes, and then reacted with a reaction mixture at 37° C. The reaction mixture contained 100 mM Tris-HCl (pH 8.2), 0.2 mM NADH, 10 mM magnesium chloride, 2 mM ammonium chloride, 10 mM potassium chloride, 0.2 mM phosphoenolpyruvate, 6.4 mM fructose-6-phosphate, 1 mM ATP and 40 μg of lactate dehydrogenase/pyruvate kinase (LDH/PK). The activity was calculated based on the decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm (Mori M. et al., Agric. Biol. Chem., 51:2671-2678, 1987; Campos G. et al., J. Biol. Chem., 259:6147-6152, 1984).
- (11) Measurement of Thermostability of Fructose-1-Phosphate Kinase
- Cells of each strain were cultured in the CM2G medium, washed twice with 0.1 M Tris-HCl (pH 7.5), and disrupted by ultrasonication. Then, the suspension was centrifuged at 13,000×g for 30 minutes, and the resultant supernatant was used as a crude enzyme solution.
- The crude enzyme solution was pretreated at 50° C. for 1, 3, 5 or 10 minutes, and then reacted with a reaction mixture at 37° C. The reaction mixture contained 100 mM Tris-HCl (pH 8.2), 0.2 mM NADH, 10 mM magnesium chloride, 2 mM ammonium chloride, 10 mM potassium chloride, 0.2 mM phosphoenolpyruvate, 6.4 mM fructose-1-phosphate, 1 mM ATP and 40 μg of lactate dehydrogenase/pyruvate kinase. The activity was calculated based on the decrease of NADH consumed by the reaction determined by measuring the absorbance at 340 nm.
- (12) Measurement of the Thermostability of Citrate Synthase
- Cells of each strain were cultured in the glutamic acid production medium, washed three times with 0.2 M sodium glutamate hydrate and 50 mM Tris-HCl (pH 7.5), and disrupted by ultrasonication. The suspension was centrifuged at 10,000 rpm for 10 minutes, and the resultant supernatant was used as a crude enzyme solution.
- The crude enzyme solution was pretreated at 50° C. for 5 minutes, and then reacted with a reaction mixture at 30° C. The reaction mixture contained 0.1 M sodium glutamate hydrate, 0.1 mM 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB), 0.3 mM acetyl-CoA and 0.5 mM oxaloacetic acid. The activity was calculated by measuring the increase of the absorbance at 412 nm of thiol-CoA (HS-CoA) mercaptide produced by the reaction (Srera, P. A., Method in Enzymol., 13:11-26, 1969; Eikmanns B. J. et al., Microbiology, 140:1817-1828, 1994).
- <4> Verification of Correlations between Amino Acid Substitutions and Thermostability of Enzymes
- For each enzyme, the number of three types of amino acid substitutions predicted in Example 2 as amino acid substitutions involved in thermostability of Corynebacterium efficiens (Lys→Arg, Ser→Ala and Ser→Thr, these directions are defined as positive directions) and the number of substitutions in the reverse directions of these amino acid substitutions (Arg→Lys, Ala→Ser and Thr→Ser, these directions are defined as negative directions) were counted. Then, the number of each substitution in the negative direction was subtracted from the number of the substitution in the positive direction to express the extents of the amino acid substitutions with numerical values (hereinafter, each obtained numerical value is referred to as “point”). Subsequently, for each enzyme, data about which enzyme derived from Corynebacterium glutamicum or enzyme derived from Corynebacterium efficiens showed higher thermostability was compared with the point. The results are shown in Table 3.
- Among the enzymes shown in Table 3, the gene sequences of Corynebacterium efficiens encoding 2-oxoglutarate dehydrogenase, isocitrate lyase, phosphofructokinase, fructose-1-phosphate kinase (phosphofructokinase), isocitrate dehydrogenase, aconitase, phosphoenolpyruvate carboxylase and citrate synthase and the amino acid sequences encoded thereby are disclosed in WO01/25447. Furthermore, the gene sequences of Corynebacterium efficiens encoding aspartate kinase, dihydrodipicolinate synthase, diaminopimelate dehydrogenase and diaminopimelate decarboxylase and the amino acid sequences encoded thereby are disclosed in Japanese Patent Laid-open Publication (Kokai) No. 2001-120270.
-
TABLE 3 Results of comparison of experimental data about enzyme thermostability with points Species showing higher Prediction Number Enzyme thermostability Point results 1 2-Oxoglutarate C. efficiens 0 Δ dehydrogenase 2 Isocitrate lyase C. efficiens 2 ◯ 3 Phosphofructokinase C. efficiens −3 X 4 Fructose-1-phosphate C. efficiens 5 ◯ kinase 5 Isocitrate dehydrogenase C. efficiens 4 ◯ 6 Aconitase C. efficiens 0 Δ 7 Phosphoenolpyruvate C. efficiens 10 ◯ carboxylase 8 Citrate synthase C. efficiens 3 ◯ 9 Aspartate kinase C. glutamicum −1 ◯ 10 Dihydrodipicolinate C. efficiens 0 Δ synthase 11 Diaminopimelate C. glutamicum −2 ◯ dehydrogenase 12 Diaminopimelate C. efficiens 2 ◯ decarboxylase - If the point is positive, the enzyme derived from Corynebacterium efficiens was expected to be more thermostable, whereas if the point was negative, the enzyme derived from Corynebacterium glutamicum was expected to be more thermostable.
- As for 2-oxoglutarate dehydrogenase, the enzyme derived from Corynebacterium efficiens was more thermostable. However, the point was 0, and thus prediction based on the point was impossible (denoted with Δ in Table 2).
- As for isocitrate lyase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 2, that is, positive. Thus, the experimental result matched the prediction (denoted with ∘ in Table 2).
- As for phosphofructokinase, the enzyme derived from Corynebacterium efficiens was more thermostabilized. However, the point was negative, and thus the experimental result did not match the prediction (denoted with X in Table 2).
- As for fructose-1-phophate kinase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 5, that is, positive. Thus, the experimental result matched the prediction.
- As for isocitrate dehydrogenase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 4, that is, positive. Thus, the experimental result matched the prediction.
- As for aconitase, the enzyme derived from Corynebacterium efficiens was more thermostabilized. However, the point was 0, and prediction based on the point was impossible.
- As for phosphoenolpyruvate carboxylase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 10, that is, positive. Thus, the experimental result matched the prediction.
- As for citrate synthase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 3, that is, positive. Thus, the experimental result matched the prediction.
- As for aspartate kinase, the enzyme derived from Corynebacterium glutamicum was more thermostabilized, and the point was −1, that is, negative. Thus, the experimental result matched the prediction.
- As for dihydrodipicolinate synthase, the enzyme derived from Corynebacterium efficiens was more thermostabilized. However, the point was 0, and thus prediction based on the point was impossible.
- As for diaminopimelate dehydrogenase, the enzyme derived from Corynebacterium glutamicum was more thermostabilized, and the point was −2, that is, negative. Thus, the experimental result matched the prediction.
- As for diaminopimelate decarboxylase, the enzyme derived from Corynebacterium efficiens was more thermostabilized, and the point was 2, that is, positive. Thus, the experimental result matched the prediction.
- As described above, the directivity of thermostabilization could be correctly predicted for 8 enzymes in 12 enzymes of which enzymatic activities were measured, and could not be predicted for 3 enzymes, whereas the experimental result did not match the point only in one enzyme. Prediction with such a high probability was possible by considering directions of only 3 amino acid substitutions.
- According to the present invention, a property of a protein such as thermostability can be modified by using only information on the primary structure without using information on the secondary structure and tertiary structure of the protein. In particular, thermostability of proteins produced by mesophilic bacteria or mesophilic bacteria themselves currently being industrially used can be improved.
- While the invention has been described with reference to preferred embodiments thereof, it will be apparent to one skilled in the art that various changes can be made, and equivalents employed, without departing from the scope of the invention. All the cited references herein, including the foreign priority document, JP 2002-57863, are incorporated as a part of this application by reference in its entirety.
Claims (9)
1. A method for improving thermostability of a protein, the method comprising introducing, into said protein, two or more amino acid substitutions selected from the group consisting of:
(i) substitution of an arginine residue for a lysine residue,
(ii) substitution of a threonine residue for a serine residue, and
(iii) substitution of an alanine residue for a serine residue.
2. The method according to claim 1 , wherein said protein is a coryneform bacterium protein.
3. The method according to claim 2 , wherein said protein is a Corynebacterium glutamicum protein.
4. A method for producing a protein having a modified thermostability, the method comprising:
(a) introducing two or more amino acid substitutions into a gene encoding a protein, wherein the two or more amino acid substitutions are selected from the group consisting of:
(i) substitution of an arginine residue for a lysine residue,
(ii) substitution of a threonine residue for a serine residue, and
(iii) substitution of an alanine residue for a serine residue; and
(b) introducing said gene obtained in (a) into a suitable host for gene expression to express the protein having the modified thermostability.
5. The method according to claim 4 , wherein said protein is a coryneform bacterium protein.
6. The method according to claim 5 , wherein said protein is a Corynebacterium glutamicum protein.
7. A method for producing a microorganism having a modified thermostability, the method comprising introducing two or more amino acid substitutions into a chromosomal DNA of a microorganism to modify a thermostability of the microorganism, wherein said two or more amino acid substitutions are selected from the group consisting of:
(i) substitution of an arginine residue for a lysine residue,
(ii) substitution of a threonine residue for a serine residue, and
(iii) substitution of an alanine residue for a serine residue.
8. The method according to claim 7 , wherein said microorganism is coryneform bacterium.
9. The method according to claim 8 wherein said microorganism is Corynebacterium glutamicum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/939,291 US20130316401A1 (en) | 2002-03-04 | 2013-07-11 | Method for Modifying a Property of a Protein |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002057863A JP2003250544A (en) | 2002-03-04 | 2002-03-04 | Methods for altering protein properties |
| JP2002-057863 | 2002-03-04 | ||
| PCT/JP2003/002495 WO2003074697A1 (en) | 2002-03-04 | 2003-03-04 | Method of modifying protein properties |
| US10/933,280 US8510053B2 (en) | 2002-03-04 | 2004-09-03 | Method for modifying a property of a protein |
| US13/939,291 US20130316401A1 (en) | 2002-03-04 | 2013-07-11 | Method for Modifying a Property of a Protein |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/933,280 Division US8510053B2 (en) | 2002-03-04 | 2004-09-03 | Method for modifying a property of a protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20130316401A1 true US20130316401A1 (en) | 2013-11-28 |
Family
ID=27784672
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/933,280 Expired - Fee Related US8510053B2 (en) | 2002-03-04 | 2004-09-03 | Method for modifying a property of a protein |
| US13/939,291 Abandoned US20130316401A1 (en) | 2002-03-04 | 2013-07-11 | Method for Modifying a Property of a Protein |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/933,280 Expired - Fee Related US8510053B2 (en) | 2002-03-04 | 2004-09-03 | Method for modifying a property of a protein |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8510053B2 (en) |
| EP (1) | EP1489174B1 (en) |
| JP (1) | JP2003250544A (en) |
| AU (1) | AU2003211625A1 (en) |
| WO (1) | WO2003074697A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003250544A (en) | 2002-03-04 | 2003-09-09 | National Institute Of Technology & Evaluation | Methods for altering protein properties |
| US7026149B2 (en) * | 2003-02-28 | 2006-04-11 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| US7060475B2 (en) * | 2003-02-28 | 2006-06-13 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| US7029893B2 (en) * | 2003-02-28 | 2006-04-18 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| US7468262B2 (en) * | 2003-05-16 | 2008-12-23 | Ajinomoto Co., Inc. | Polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum |
| BRPI0413030A (en) * | 2003-07-29 | 2006-10-03 | Ajinomoto Kk | methods for determining at least one substance production that affects metabolic flow using cells, for creating a bacterial strain having an ability to produce substance, and for producing a substance, program for determining at least one substance production that affects metabolic flow using cells, and computer readable registration medium |
| US7693664B2 (en) | 2004-02-23 | 2010-04-06 | Japan Agency For Marine-Earth Science And Technology | Method and computer program product for determining whether or not a test protein has thermostability |
| JP4616660B2 (en) * | 2004-02-23 | 2011-01-19 | 独立行政法人海洋研究開発機構 | Prediction method of thermostable proteins from non-thermophilic bacteria based on amino acid composition of thermophilic bacteria and highly related non-thermophilic bacteria |
| JP4490302B2 (en) * | 2004-03-08 | 2010-06-23 | 独立行政法人海洋研究開発機構 | Prediction program for heat-resistant protein and recording medium thereof |
| JP2007117082A (en) * | 2005-09-27 | 2007-05-17 | Ajinomoto Co Inc | L-amino acid producing bacteria and preparation process of l-amino acid |
| JP2009118740A (en) * | 2006-03-03 | 2009-06-04 | Ajinomoto Co Inc | Method for producing l-amino acid |
| JP2010017081A (en) * | 2006-10-10 | 2010-01-28 | Ajinomoto Co Inc | Method for producing l-amino acid |
| EP2094858B1 (en) * | 2006-12-11 | 2015-02-18 | Ajinomoto Co., Inc. | Method for producing an l-amino acid |
| JP2010110217A (en) * | 2007-02-22 | 2010-05-20 | Ajinomoto Co Inc | L-amino acid-producing microorganism and method for producing l-amino acid |
| JP2010130899A (en) | 2007-03-14 | 2010-06-17 | Ajinomoto Co Inc | Microorganism producing l-glutamic acid-based amino acid, and method for producing amino acid |
| JPWO2008133131A1 (en) * | 2007-04-16 | 2010-07-22 | 味の素株式会社 | Method for producing organic acid |
| CN101688176B (en) | 2007-04-17 | 2013-11-06 | 味之素株式会社 | Method for production of acidic substance having carboxyl group |
| JP2010263790A (en) * | 2007-09-04 | 2010-11-25 | Ajinomoto Co Inc | Amino acid-producing microorganism and method for producing amino acid |
| RU2395579C2 (en) * | 2007-12-21 | 2010-07-27 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) | METHOD OF PRODUCING L-AMINO ACIDS USING Escherichia GENUS BACTERIA |
| JP2010226957A (en) * | 2007-10-17 | 2010-10-14 | Ajinomoto Co Inc | Method for producing l-amino acid |
| KR20100120663A (en) | 2008-01-23 | 2010-11-16 | 아지노모토 가부시키가이샤 | Method of producing l-amino acid |
| JP2011167071A (en) * | 2008-05-22 | 2011-09-01 | Ajinomoto Co Inc | Method for producing l-amino acid |
| WO2009154280A1 (en) * | 2008-06-19 | 2009-12-23 | 味の素株式会社 | Agent for preventing excessive appetite |
| EP2343371B1 (en) | 2008-09-05 | 2015-10-21 | Ajinomoto Co., Inc. | Method for producing l-amino acid |
| US9657328B2 (en) * | 2008-12-12 | 2017-05-23 | Korean Research Institute Of Bioscience And Biotechnology | Methods for modulating thermostability and acid tolerance of microbes |
| JP2012223092A (en) | 2009-08-28 | 2012-11-15 | Ajinomoto Co Inc | Method for producing l-amino acid |
| JP2013074795A (en) | 2010-02-08 | 2013-04-25 | Ajinomoto Co Inc | MUTANT rpsA GENE AND METHOD FOR PRODUCING L-AMINO ACID |
| JP2014036576A (en) | 2010-12-10 | 2014-02-27 | Ajinomoto Co Inc | Method for producing l-amino acids |
| EP2778228B1 (en) | 2011-11-11 | 2017-05-17 | Ajinomoto Co., Inc. | Method for producing 2-ketoglutaric acid and derivatives thereof by using a bacterium from the genus pantoea or the genus corynebacterium |
| JP2017131111A (en) | 2014-06-03 | 2017-08-03 | 味の素株式会社 | Method for producing L-amino acid |
| EP3877515A1 (en) * | 2018-11-09 | 2021-09-15 | Wageningen Universiteit | Microbial hosts engineered for increased tolerance to temperature shifts |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL341895A1 (en) | 1999-08-12 | 2001-02-26 | Ajinomoto Kk | Plasmide autonomously replicable in corynebacter bacteria |
| EP1240524B1 (en) * | 1999-12-23 | 2010-11-17 | Genencor International, Inc. | Cellulase from t. reesei with improved thermostability |
| JP2002247991A (en) * | 2000-07-04 | 2002-09-03 | Ajinomoto Co Inc | Method for improving heat resistance of protein, protein having heat resistance improved by the method and nucleic acid encoding the protein |
| EP1217076B1 (en) * | 2000-12-22 | 2006-06-14 | Ajinomoto Co., Inc. | Method of producing a target substance by fermentation |
| JP3812569B2 (en) * | 2001-06-22 | 2006-08-23 | 和光純薬工業株式会社 | Resist composition |
| JP2003250544A (en) | 2002-03-04 | 2003-09-09 | National Institute Of Technology & Evaluation | Methods for altering protein properties |
| US6911332B2 (en) * | 2002-06-12 | 2005-06-28 | Ajinomoto Co., Inc. | Isolated polynucleotides encoding d-arabino-3-hexulose-6-phosphate synthases from Methylophilus methylotrophus |
| US7060475B2 (en) * | 2003-02-28 | 2006-06-13 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| US7026149B2 (en) * | 2003-02-28 | 2006-04-11 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| US7029893B2 (en) * | 2003-02-28 | 2006-04-18 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| US7468262B2 (en) * | 2003-05-16 | 2008-12-23 | Ajinomoto Co., Inc. | Polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum |
-
2002
- 2002-03-04 JP JP2002057863A patent/JP2003250544A/en active Pending
-
2003
- 2003-03-04 AU AU2003211625A patent/AU2003211625A1/en not_active Abandoned
- 2003-03-04 WO PCT/JP2003/002495 patent/WO2003074697A1/en not_active Ceased
- 2003-03-04 EP EP03743597.1A patent/EP1489174B1/en not_active Expired - Lifetime
-
2004
- 2004-09-03 US US10/933,280 patent/US8510053B2/en not_active Expired - Fee Related
-
2013
- 2013-07-11 US US13/939,291 patent/US20130316401A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003250544A (en) | 2003-09-09 |
| EP1489174A1 (en) | 2004-12-22 |
| WO2003074697A1 (en) | 2003-09-12 |
| EP1489174A4 (en) | 2005-03-16 |
| AU2003211625A1 (en) | 2003-09-16 |
| EP1489174B1 (en) | 2015-08-12 |
| US20050233308A1 (en) | 2005-10-20 |
| US8510053B2 (en) | 2013-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8510053B2 (en) | Method for modifying a property of a protein | |
| CN111315876B (en) | ATP phosphoribosyltransferase mutant and method for producing L-histidine using same | |
| EP1074626B1 (en) | Genes for lysine biosynthetic system derived from thermophilic bacteria | |
| KR101947959B1 (en) | A modified homoserine dehydrogenase and a method for producing homoserine or L- amino acid derived from homoserine using the same | |
| RU2683208C1 (en) | Pyruvate dehydrogenase mutant, mutant-containing microorganism, and method for producing l-amino acid using microorganism | |
| US20240327884A1 (en) | Atp-prt variant with reduced feedback inhibition by histidine, and histidine-producing strain expressing same | |
| US9896705B2 (en) | L-arabinose isomerase variants with improved conversion activity and method for production of D-tagatose using them | |
| CN108251396B (en) | 5-amino-acetopropionic acid synthetase mutant and host cell and application thereof | |
| CN114096663B (en) | Microorganism having enhanced 3-methyl-2-oxobutanoic acid hydroxymethyltransferase activity and use thereof | |
| JP2023110008A (en) | Glutamine synthetase mutant polypeptide and L-glutamine production method using the same | |
| KR20020042703A (en) | Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant Coryneform bacterium | |
| US20110177568A1 (en) | Method of L-Lysine Production | |
| JP2024537520A (en) | Novel YhhS mutant and method for producing O-phosphoserine, cysteine and their derivatives using the same | |
| US20200224226A1 (en) | Heterologous expression of thermophilic lysine decarboxylase and uses thereof | |
| JP4257730B2 (en) | Acyl CoA oxidase, its gene, recombinant DNA, and method for producing acyl CoA oxidase | |
| RU2824530C1 (en) | Version of isopropyl malate synthase and method of producing l-leucine using same | |
| Kang et al. | Cloning, sequence analysis, and characterization of the astA gene encoding an arylsulfate sulfotransferase from Citrobacter freundii | |
| Iwama et al. | Comparative characterization of the oah2 gene homologous to the oah1 of Thermus thermophilus HB8 | |
| Ubiyvovk et al. | Cloning and functional analysis of the GSH1/MET1 gene complementing cysteine and glutathione auxotrophy of the methylotrophic yeast Hansenula polymorpha | |
| CN114921435A (en) | Ornithine acetyltransferase mutant, encoding gene, plasmid, genetically engineered bacteria and application | |
| US20250011750A1 (en) | Variant of aspartate 1-decarboxylase derived from t. castaneum and microorganisms including same | |
| CN119156444A (en) | Microorganism having enhanced aspartic acid 1-decarboxylase activity derived from orychophragmus violaceus and use thereof | |
| Nishio et al. | Comparative Whole Genome Sequence Analysis of Corynebacteria | |
| JP2005034086A (en) | ACYL-CoA OXIDASE, GENE THEREOF, RECOMBINANT DNA, AND METHOD FOR PRODUCING ACYL-CoA OXIDASE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: AJINOMOTO CO., INC., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NISHIO, YOSUKE;KIMURA, EIICHIRO;USUDA, YOSHIHIRO;AND OTHERS;SIGNING DATES FROM 20041117 TO 20041207;REEL/FRAME:032668/0320 Owner name: NATIONAL INSTITUTE OF TECHNOLOGY AND EVALUATION, J Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NISHIO, YOSUKE;KIMURA, EIICHIRO;USUDA, YOSHIHIRO;AND OTHERS;SIGNING DATES FROM 20041117 TO 20041207;REEL/FRAME:032668/0320 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |